candidate_genes,disease,celltype,y,user_question,full_query
"['BBOX1', 'CCDC127', 'NDUFAF3', 'RNASE1', 'INTS4']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFAF3,"Which gene—BBOX1, CCDC127, NDUFAF3, RNASE1, or INTS4—shows the highest cell-type specificity in CD4-positive alpha‑beta cytotoxic T cells for targeting follicular lymphoma?","Which gene—BBOX1, CCDC127, NDUFAF3, RNASE1, or INTS4—shows the highest cell-type specificity in CD4-positive alpha‑beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma within the PINNACLE dataset and retrieve their corresponding cell-type–specific embeddings. Next, determine the intersection between these targets and the cd4-positive alpha-beta cytotoxic T cell-activated genes in PINNACLE. For the overlapping set, calculate the average embedding and then compute the cosine similarity between this reference embedding and each individual target. Finally, if one gene displays a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAMDC2', 'TSR1', 'TYK2', 'AVEN', 'RIPOR3']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TYK2,"Among MAMDC2, TSR1, TYK2, AVEN, and RIPOR3, which gene exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells for targeting follicular lymphoma?","Among MAMDC2, TSR1, TYK2, AVEN, and RIPOR3, which gene exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the CD4-positive, alpha-beta cytotoxic T cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set as a reference and calculate the cosine similarity between the reference and each individual target embedding. If one gene exhibits a substantially higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ERCC2', 'DIMT1', 'SELENOH', 'CD38', 'CASP8AP2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,CD38,"Among ERCC2, DIMT1, SELENOH, CD38, and CASP8AP2, which gene exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Among ERCC2, DIMT1, SELENOH, CD38, and CASP8AP2, which gene exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the cd4-positive alpha-beta cytotoxic T cell activation genes in PINNACLE. Compute the average embedding of the overlapping targets, then calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['SAT1', 'ISG20', 'CYFIP2', 'PRPF18', 'MT-ND4L']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,MT-ND4L,"Among the genes SAT1, ISG20, CYFIP2, PRPF18, and MT-ND4L, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes SAT1, ISG20, CYFIP2, PRPF18, and MT-ND4L, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the experimentally validated therapeutic targets for follicular lymphoma and obtain their cell type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in CD4-positive, alpha-beta cytotoxic T cells in PINNACLE, thereby defining a subset of cell type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping genes as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TRIM16', 'CDC42EP4', 'ZNF703', 'NRP2', 'NDUFV2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFV2,"Which gene among TRIM16, CDC42EP4, ZNF703, NRP2, and NDUFV2 exhibits the highest specificity in cd4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene among TRIM16, CDC42EP4, ZNF703, NRP2, and NDUFV2 exhibits the highest specificity in cd4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Using PINNACLE data, first identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings. Then, from the CD4-positive, alpha-beta cytotoxic T cell population, determine which activated genes overlap with these targets. Calculate the average embedding for this overlapping set as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ELOC', 'KCNH1', 'SLC16A3', 'NDUFB4', 'SMC3']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFB4,"Which gene among ELOC, KCNH1, SLC16A3, NDUFB4, and SMC3 demonstrates the most specific expression in CD4-positive alpha-beta cytotoxic T cells, thereby representing the single best candidate for targeted follicular lymphoma therapy?","Which gene among ELOC, KCNH1, SLC16A3, NDUFB4, and SMC3 demonstrates the most specific expression in CD4-positive alpha-beta cytotoxic T cells, thereby representing the single best candidate for targeted follicular lymphoma therapy? Using PINNACLE, first identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Then, determine which of these targets overlap with the genes activated in cd4-positive alpha-beta cytotoxic T cells. Compute the average embedding for the overlapping genes and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UPF3B', 'HLA-DRB1', 'RPL13AP17', 'GJB4', 'RABAC1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,HLA-DRB1,"Among the genes UPF3B, HLA-DRB1, RPL13AP17, GJB4, and RABAC1, which one exhibits the highest specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Among the genes UPF3B, HLA-DRB1, RPL13AP17, GJB4, and RABAC1, which one exhibits the highest specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the gene set activated in CD4-positive alpha-beta cytotoxic T cells in PINNACLE. Calculate the average embedding of the overlapping genes to serve as a reference, then compute the cosine similarity between this reference vector and each individual target’s embedding. Finally, if a single gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRTN3', 'COL6A2', 'CD3G', 'MYOF', 'TBX22']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,CD3G,"Among the genes PRTN3, COL6A2, CD3G, MYOF, and TBX22, which one exhibits the highest specificity for CD4-positive alpha-beta cytotoxic T cells in the context of targeting follicular lymphoma?","Among the genes PRTN3, COL6A2, CD3G, MYOF, and TBX22, which one exhibits the highest specificity for CD4-positive alpha-beta cytotoxic T cells in the context of targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD4-positive alpha-beta cytotoxic T cell–activated genes in PINNACLE. Using the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target’s embedding. If a gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RNF123', 'CORO1C', 'DLG1', 'TNFRSF4', 'FAM110A']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TNFRSF4,"Among the genes RNF123, CORO1C, DLG1, TNFRSF4, and FAM110A, which shows the highest cell-type specificity in CD4-positive αβ cytotoxic T cells for targeting follicular lymphoma?","Among the genes RNF123, CORO1C, DLG1, TNFRSF4, and FAM110A, which shows the highest cell-type specificity in CD4-positive αβ cytotoxic T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, from the genes activated in cd4-positive alpha-beta cytotoxic T cells in PINNACLE, determine the overlap with the follicular lymphoma targets to form a cell-type–specific target set. Calculate the average embedding of these overlapping genes, and then compute the cosine similarity between this average and each individual target gene’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DENND2C', 'STYX', 'ARHGAP18', 'KIAA0319', 'NDUFC2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFC2,"Among DENND2C, STYX, ARHGAP18, KIAA0319, and NDUFC2, which gene exhibits the greatest cell-type specificity in CD4-positive alpha‐beta cytotoxic T cells for targeting follicular lymphoma?","Among DENND2C, STYX, ARHGAP18, KIAA0319, and NDUFC2, which gene exhibits the greatest cell-type specificity in CD4-positive alpha‐beta cytotoxic T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell‐type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of activated genes from CD4-positive alpha-beta cytotoxic T cells in PINNACLE, as these represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding of the overlapping genes to serve as a reference, then calculate the cosine similarity between this reference and each individual target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CLIC5', 'PBRM1', 'DDB1', 'PELI2', 'C7orf26']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,DDB1,"Which gene—CLIC5, PBRM1, DDB1, PELI2, or C7orf26—exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells with respect to targeting follicular lymphoma?","Which gene—CLIC5, PBRM1, DDB1, PELI2, or C7orf26—exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells with respect to targeting follicular lymphoma? Which validated therapeutic targets for follicular lymphoma (as characterized by PINNACLE cell-type–specific embeddings) overlap with genes activated in cd4-positive alpha-beta cytotoxic T cells? Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['DDX49', 'TENT2', 'PICK1', 'TMEM144', 'IFNAR2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,IFNAR2,"Which gene among DDX49, TENT2, PICK1, TMEM144, and IFNAR2 exhibits the highest expression specificity in CD4-positive alpha-beta cytotoxic T cells for potential targeting in follicular lymphoma?","Which gene among DDX49, TENT2, PICK1, TMEM144, and IFNAR2 exhibits the highest expression specificity in CD4-positive alpha-beta cytotoxic T cells for potential targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the gene set associated with CD4-positive alpha-beta cytotoxic T cell activation in PINNACLE. For the overlapping genes, compute their average embedding as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDK4', 'SYP', 'EPHA5', 'CSN1S1', 'GINM1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,CDK4,"Among the genes CDK4, SYP, EPHA5, CSN1S1, and GINM1, which exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for therapeutic targeting of follicular lymphoma?","Among the genes CDK4, SYP, EPHA5, CSN1S1, and GINM1, which exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for therapeutic targeting of follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which CD4-positive alpha-beta cytotoxic T-cell activation genes in PINNACLE intersect with these targets—these overlapping genes constitute the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['MRPL49', 'UPF2', 'NDUFAB1', 'PRR16', 'SYPL1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFAB1,"Among the genes MRPL49, UPF2, NDUFAB1, PRR16, and SYPL1, which one exhibits the highest specificity for CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes MRPL49, UPF2, NDUFAB1, PRR16, and SYPL1, which one exhibits the highest specificity for CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the genes associated with activated cd4-positive alpha-beta cytotoxic T cells in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC4A1', 'DAXX', 'LAG3', 'EFHC1', 'MED13']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,LAG3,"Among the genes SLC4A1, DAXX, LAG3, EFHC1, and MED13, which displays the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells relevant for targeting follicular lymphoma?","Among the genes SLC4A1, DAXX, LAG3, EFHC1, and MED13, which displays the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells relevant for targeting follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the CD4-positive alpha-beta cytotoxic T cell–activated genes in PINNACLE. Compute the average embedding of this overlapping set to serve as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['WDR41', 'RASSF1', 'TUBB', 'LTN1', 'GDF6']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TUBB,"Among the following genes—WDR41, RASSF1, TUBB, LTN1, and GDF6—which one exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the following genes—WDR41, RASSF1, TUBB, LTN1, and GDF6—which one exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection with genes that are activated in CD4-positive αβ cytotoxic T cells, which will define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this gene set and evaluate the cosine similarity between this average and each individual target embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BCL2A1', 'ZBBX', 'CBLN2', 'PCDHA10', 'SLC4A10']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,BCL2A1,"Among the genes BCL2A1, ZBBX, CBLN2, PCDHA10, and SLC4A10, which one demonstrates the highest cell-type specificity in CD4+ alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Among the genes BCL2A1, ZBBX, CBLN2, PCDHA10, and SLC4A10, which one demonstrates the highest cell-type specificity in CD4+ alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the cd4-positive alpha-beta cytotoxic T cell–activated genes in the PINNACLE dataset. Compute the average embedding of the overlapping targets to serve as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HIPK2', 'HMGCS1', 'GPR89B', 'GMNN', 'NDUFA8']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFA8,"Among HIPK2, HMGCS1, GPR89B, GMNN, and NDUFA8, which gene shows the highest cell-type specificity in CD4-positive αβ cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma?","Among HIPK2, HMGCS1, GPR89B, GMNN, and NDUFA8, which gene shows the highest cell-type specificity in CD4-positive αβ cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma? Retrieve the verified therapeutic targets for follicular lymphoma from PINNACLE along with their cell-type–specific embeddings. Identify which of these targets intersect with the set of genes activated in CD4-positive alpha-beta cytotoxic T cells. For the overlapping genes, compute the average embedding to serve as a reference profile, then calculate the cosine similarity between this reference and each individual gene's embedding. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PSMA5', 'MAPRE2', 'DYNC2LI1', 'TEF', 'NDUFA4']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFA4,"Among PSMA5, MAPRE2, DYNC2LI1, TEF, and NDUFA4, which gene exhibits the highest expression specificity in CD4-positive alpha-beta T cells relevant for targeted therapy against follicular lymphoma?","Among PSMA5, MAPRE2, DYNC2LI1, TEF, and NDUFA4, which gene exhibits the highest expression specificity in CD4-positive alpha-beta T cells relevant for targeted therapy against follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma that overlap with the CD4-positive alpha-beta cytotoxic T cell activation gene set in the PINNACLE database. Retrieve their cell-type–specific embeddings, compute the average embedding as a reference, and then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KCNE5', 'SNTG1', 'APBA1', 'TBC1D25', 'PRKCB']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,PRKCB,"Which gene, among KCNE5, SNTG1, APBA1, TBC1D25, and PRKCB, shows the highest expression specificity in CD4-positive alpha-beta T cells relevant for targeting follicular lymphoma?","Which gene, among KCNE5, SNTG1, APBA1, TBC1D25, and PRKCB, shows the highest expression specificity in CD4-positive alpha-beta T cells relevant for targeting follicular lymphoma? Using PINNACLE, identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Determine the overlap between these targets and the genes expressed in activated CD4-positive alpha-beta cytotoxic T cells, defining this intersection as the cell-type–specific targets for follicular lymphoma. Next, calculate the average embedding of this gene set and compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based explanation of its biological relevance."
"['CEL', 'NFKBIL1', 'LINC00482', 'NDUFS4', 'XRCC2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS4,"Among the genes CEL, NFKBIL1, LINC00482, NDUFS4, and XRCC2, which exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells as a potential target for follicular lymphoma?","Among the genes CEL, NFKBIL1, LINC00482, NDUFS4, and XRCC2, which exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells as a potential target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the genes flagged as activated in naive thymus-derived CD4+ alpha-beta T cells within PINNACLE. Define this overlap as the cell-type–specific targets for follicular lymphoma, calculate the average embedding for this subset as a reference, and then compute the cosine similarity between the reference and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AKAP7', 'PPM1A', 'CDK4', 'UBE2O', 'VSX2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,CDK4,"Which gene among AKAP7, PPM1A, CDK4, UBE2O, and VSX2 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, making it the most appropriate candidate for targeting follicular lymphoma?","Which gene among AKAP7, PPM1A, CDK4, UBE2O, and VSX2 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, making it the most appropriate candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the naive thymus–derived CD4-positive αβ T cell–activated genes in PINNACLE; this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these genes to serve as a reference, and calculate the cosine similarity between this reference and the embedding of each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA4', 'LARS1', 'PAK5', 'MFGE8', 'NCBP2AS2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFA4,"Among NDUFA4, LARS1, PAK5, MFGE8, and NCBP2AS2, which gene exhibits the highest specificity in naive thymus-derived CD4+ alpha-beta T cells to serve as the best target for follicular lymphoma therapy?","Among NDUFA4, LARS1, PAK5, MFGE8, and NCBP2AS2, which gene exhibits the highest specificity in naive thymus-derived CD4+ alpha-beta T cells to serve as the best target for follicular lymphoma therapy? Retrieve the verified therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the set of naive thymus-derived CD4-positive alpha-beta T cell–activated genes in PINNACLE. Calculate the average embedding of the overlapping genes and then determine the cosine similarity between this composite embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['ST8SIA2', 'EIF3J', 'OSR1', 'NDUFS8', 'RAB32']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS8,"Among the genes ST8SIA2, EIF3J, OSR1, NDUFS8, and RAB32, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells, making it the most promising target for follicular lymphoma?","Among the genes ST8SIA2, EIF3J, OSR1, NDUFS8, and RAB32, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells, making it the most promising target for follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma in PINNACLE and extract their cell-type–specific embeddings. Then, from the set of naive thymus-derived CD4+ αβ T cell-activated genes in PINNACLE, determine the overlapping genes to define cell-type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping targets and calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['KRTAP4-5', 'ZSCAN22', 'COL9A3', 'SLC12A9', 'NDUFAF2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFAF2,"Among the genes KRTAP4-5, ZSCAN22, COL9A3, SLC12A9, and NDUFAF2, which shows the highest specificity in naive thymus-derived CD4+ αβ T cells, making it the most appropriate candidate target for follicular lymphoma?","Among the genes KRTAP4-5, ZSCAN22, COL9A3, SLC12A9, and NDUFAF2, which shows the highest specificity in naive thymus-derived CD4+ αβ T cells, making it the most appropriate candidate target for follicular lymphoma? What are the validated therapeutic targets for follicular lymphoma? Retrieve their cell-type–specific embeddings from PINNACLE and identify which naive thymus–derived CD4-positive alpha-beta T cell–activated genes overlap with these targets. Then, compute the average embedding for the overlapping set and calculate the cosine similarity between this reference and each individual gene's embedding. If one gene displays a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GNPNAT1', 'ARHGEF25', 'ZNF382', 'NDUFS3', 'BMP2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS3,"Which gene—GNPNAT1, ARHGEF25, ZNF382, NDUFS3, or BMP2—exhibits the most specific expression in naive, thymus-derived, CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene—GNPNAT1, ARHGEF25, ZNF382, NDUFS3, or BMP2—exhibits the most specific expression in naive, thymus-derived, CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, identify which genes in the PINNACLE repository, associated with naive thymus-derived CD4+ alpha-beta T cell activation, overlap with these targets. These overlapping genes represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set to establish a reference, then calculate the cosine similarity between the reference and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LONRF3', 'PTPRD', 'TRIM51', 'PCNP', 'CDK9']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,CDK9,"Among the genes LONRF3, PTPRD, TRIM51, PCNP, and CDK9, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma?","Among the genes LONRF3, PTPRD, TRIM51, PCNP, and CDK9, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma? Determine the validated therapeutic targets for follicular lymphoma from PINNACLE and retrieve their corresponding cell-type specific embeddings. Then, identify the overlapping genes between these targets and the set of naive thymus-derived CD4-positive alpha-beta T cell-activated genes available in PINNACLE. Calculate the average embedding (reference vector) of this overlapping set, and compute the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PYROXD2', 'JPH1', 'MT-ND2', 'CACNA1D', 'MAP2K3']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,MT-ND2,"Which gene among PYROXD2, JPH1, MT-ND2, CACNA1D, and MAP2K3 exhibits the highest specificity for naive thymus-derived CD4+ αβ T cells, making it the best candidate for targeted intervention in follicular lymphoma?","Which gene among PYROXD2, JPH1, MT-ND2, CACNA1D, and MAP2K3 exhibits the highest specificity for naive thymus-derived CD4+ αβ T cells, making it the best candidate for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which genes from the naive thymus–derived CD4-positive alpha-beta T-cell activation set in PINNACLE overlap with these therapeutic targets. Using the overlapping set, compute their average embedding as a reference and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows substantially higher similarity than all others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['SERPINA3', 'PRKCB', 'LETMD1', 'TLE4', 'LINC00242']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,PRKCB,"Among SERPINA3, PRKCB, LETMD1, TLE4, and LINC00242, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for potential targeting of follicular lymphoma?","Among SERPINA3, PRKCB, LETMD1, TLE4, and LINC00242, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for potential targeting of follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus-derived CD4-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets to define the relevant cell-type–specific target set. Compute the average embedding of this set as a reference and calculate the cosine similarity between each individual target’s embedding and this reference. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ITPR2', 'STXBP3', 'MED24', 'MT-ND4', 'PPL']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,MT-ND4,"Among the genes ITPR2, STXBP3, MED24, MT-ND4, and PPL, which one exhibits the highest cell-type specificity in naive, thymus-derived, CD4-positive, αβ T cells for targeting follicular lymphoma?","Among the genes ITPR2, STXBP3, MED24, MT-ND4, and PPL, which one exhibits the highest cell-type specificity in naive, thymus-derived, CD4-positive, αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma by retrieving their cell-type–specific embeddings from PINNACLE. Then, focus on the subset of naive, thymus-derived, CD4-positive alpha-beta T cell–activated genes in PINNACLE and identify those that overlap with the therapeutic targets. For these overlapping genes, compute the average cell-type–specific embedding as a reference, and calculate the cosine similarity between this reference vector and the embedding of each individual gene. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance to follicular lymphoma."
"['APEH', 'AQP5', 'FAM71F2', 'NDUFB6', 'FOXA1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFB6,"Among the genes APEH, AQP5, FAM71F2, NDUFB6, and FOXA1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells, making it the most suitable candidate for targeting follicular lymphoma?","Among the genes APEH, AQP5, FAM71F2, NDUFB6, and FOXA1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells, making it the most suitable candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus-derived CD4-positive αβ T cell-activated genes in PINNACLE to establish the relevant cell-type–specific targets. Compute the average embedding of the overlapping set, then calculate the cosine similarity between this average reference and each individual target embedding. If a single gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SMG7', 'SF3B1', 'GLCCI1', 'NDUFA10', 'EML5']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFA10,"Among the genes SMG7, SF3B1, GLCCI1, NDUFA10, and EML5, which one exhibits the highest cell-type specificity in naïve, thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes SMG7, SF3B1, GLCCI1, NDUFA10, and EML5, which one exhibits the highest cell-type specificity in naïve, thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embedding profiles from PINNACLE. Next, determine which of these targets overlap with genes associated with naive thymus-derived CD4+ alpha-beta T cell activation in PINNACLE. For the overlapping gene set, compute an average embedding profile to serve as a reference and calculate the cosine similarity between this reference and each individual gene's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['BCL2A1', 'CCR1', 'CD34', 'FPR2', 'COPS3']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,BCL2A1,"Among the genes BCL2A1, CCR1, CD34, FPR2, and COPS3, which one exhibits the highest specificity in naive thymus-derived CD4+ αβ T cells for targeting follicular lymphoma?","Among the genes BCL2A1, CCR1, CD34, FPR2, and COPS3, which one exhibits the highest specificity in naive thymus-derived CD4+ αβ T cells for targeting follicular lymphoma? Identify the therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus-derived CD4-positive αβ T cell activation genes overlap with these targets in PINNACLE. For the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IL6R', 'CFAP410', 'TLK2', 'PDE10A', 'CA8']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,IL6R,"Which gene among IL6R, CFAP410, TLK2, PDE10A, and CA8 exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells for targeting follicular lymphoma?","Which gene among IL6R, CFAP410, TLK2, PDE10A, and CA8 exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells for targeting follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the naive thymus-derived CD4-positive alpha-beta T cell–activated genes in PINNACLE. For this overlapping set, compute the average embedding to serve as a reference and then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['PML', 'TM4SF18', 'LINC00526', 'BMP2', 'CUL4A']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,CUL4A,"Among PML, TM4SF18, LINC00526, BMP2, and CUL4A, which gene exhibits the highest specificity in naive thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among PML, TM4SF18, LINC00526, BMP2, and CUL4A, which gene exhibits the highest specificity in naive thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings using PINNACLE. Next, from the subset of naive thymus-derived, CD4-positive, alpha-beta T cell–activated genes in PINNACLE, determine the intersection with these targets to define follicular lymphoma–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC00588', 'TRIM24', 'MT-ND1', 'ZNF578', 'CCDC197']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,MT-ND1,"Which gene among LINC00588, TRIM24, MT-ND1, ZNF578, and CCDC197 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, thereby representing the best candidate for targeted follicular lymphoma therapy?","Which gene among LINC00588, TRIM24, MT-ND1, ZNF578, and CCDC197 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, thereby representing the best candidate for targeted follicular lymphoma therapy? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the naive thymus-derived CD4-positive alpha-beta T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and evaluate the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['WFS1', 'LCK', 'KIF1C', 'MC4R', 'CHD4']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,LCK,"Which gene among WFS1, LCK, KIF1C, MC4R, and CHD4 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among WFS1, LCK, KIF1C, MC4R, and CHD4 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the naive, thymus-derived, CD4-positive, alpha-beta T cell–activated genes in PINNACLE overlap with these targets; this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KCNMB4', 'CELF2', 'SLC1A1', 'UBC', 'HHLA3']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,CELF2,"Which gene among KCNMB4, CELF2, SLC1A1, UBC, and HHLA3 exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among KCNMB4, CELF2, SLC1A1, UBC, and HHLA3 exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes among the naive thymus-derived CD4-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual gene’s embedding. If one gene shows a markedly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its potential biological relevance."
"['HOXB9', 'MAN1A2', 'NDUFAF3', 'RBIS', 'NCS1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFAF3,"Which gene among HOXB9, MAN1A2, NDUFAF3, RBIS, and NCS1 demonstrates the highest cell-type specificity within naive thymus-derived CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene among HOXB9, MAN1A2, NDUFAF3, RBIS, and NCS1 demonstrates the highest cell-type specificity within naive thymus-derived CD4-positive alpha-beta T cells for targeting follicular lymphoma? Using PINNACLE, identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with naive thymus-derived, CD4-positive, alpha-beta T cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. Nominate the gene with a markedly higher cosine similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DKC1', 'SYT13', 'NDUFS7', 'GTF2H2C_2', 'MAGOH']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS7,"Which gene among DKC1, SYT13, NDUFS7, GTF2H2C_2, and MAGOH exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among DKC1, SYT13, NDUFS7, GTF2H2C_2, and MAGOH exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of naive thymus-derived CD4-positive alpha-beta T cell-activated genes available in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for the overlapping genes, then calculate the cosine similarity between this reference embedding and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['TADA2B', 'PALMD', 'NDUFAB1', 'TPGS2', 'EME2']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFAB1,"Which gene among TADA2B, PALMD, NDUFAB1, TPGS2, and EME2 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among TADA2B, PALMD, NDUFAB1, TPGS2, and EME2 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the optimal candidate for targeting follicular lymphoma? Using validated therapeutic targets for follicular lymphoma, extract their cell type–specific embeddings from the PINNACLE dataset. Identify the overlap between these therapeutic targets and the gene set activated in naive thymus-derived CD8-positive alpha-beta T cells in PINNACLE. Compute the average embedding vector for the overlapping genes, then determine the cosine similarity between this reference vector and each individual target's embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ACP2', 'PEX2', 'SSBP1', 'NDUFB10', 'DPH1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFB10,"Among the genes ACP2, PEX2, SSBP1, NDUFB10, and DPH1, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma?","Among the genes ACP2, PEX2, SSBP1, NDUFB10, and DPH1, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the naive thymus-derived CD8+ alpha-beta T cell–activated gene set in PINNACLE; these overlapping genes represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and the embedding of each individual gene. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['INPP4A', 'PSMD2', 'ARID1B', 'CD300LG', 'PPIA']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,PPIA,"Among the genes INPP4A, PSMD2, ARID1B, CD300LG, and PPIA, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma?","Among the genes INPP4A, PSMD2, ARID1B, CD300LG, and PPIA, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the naive thymus-derived, CD8-positive, αβ T cell-activated genes in PINNACLE. For the overlapping set, calculate the average embedding to serve as a reference vector, and then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DEF8', 'GBA2', 'FOXS1', 'HSP90AB1', 'JADE3']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AB1,"Among the genes DEF8, GBA2, FOXS1, HSP90AB1, and JADE3, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for use in targeting follicular lymphoma?","Among the genes DEF8, GBA2, FOXS1, HSP90AB1, and JADE3, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for use in targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of the naive, thymus-derived, CD8-positive αβ T cell activation genes in PINNACLE overlap with these targets, yielding the relevant set for follicular lymphoma. Compute the average embedding of this overlapping set to create a reference vector, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IDI2', 'GPR17', 'NDUFV2', 'PLOD2', 'DYNC2H1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFV2,"Which gene—IDI2, GPR17, NDUFV2, PLOD2, or DYNC2H1—exhibits the highest specificity for naive thymus-derived CD8+ alpha-beta T cells, making it the most promising target for follicular lymphoma therapy?","Which gene—IDI2, GPR17, NDUFV2, PLOD2, or DYNC2H1—exhibits the highest specificity for naive thymus-derived CD8+ alpha-beta T cells, making it the most promising target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes from the naive, thymus-derived, CD8-positive, αβ T cell activation dataset overlap with these targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average reference and each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance in follicular lymphoma."
"['TLR4', 'FHL3', 'H3C14', 'NDUFS7', 'ANAPC15']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFS7,"Which gene—among TLR4, FHL3, H3C14, NDUFS7, and ANAPC15—exhibits the most cell-type specific expression in naive thymus-derived CD8-positive αβ T cells for targeting follicular lymphoma?","Which gene—among TLR4, FHL3, H3C14, NDUFS7, and ANAPC15—exhibits the most cell-type specific expression in naive thymus-derived CD8-positive αβ T cells for targeting follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma present in the PINNACLE database. Next, from the naive, thymus-derived, CD8-positive αβ T cell activation gene set in PINNACLE, pinpoint the genes that overlap with these targets. Calculate the average embedding for this overlapping set and determine the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance in follicular lymphoma."
"['MIRLET7I', 'GOLGA2', 'ANGPTL7', 'SH3BP2', 'IL2RB']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,IL2RB,"Which gene among MIRLET7I, GOLGA2, ANGPTL7, SH3BP2, and IL2RB exhibits the highest specificity in naive, thymus-derived CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among MIRLET7I, GOLGA2, ANGPTL7, SH3BP2, and IL2RB exhibits the highest specificity in naive, thymus-derived CD8+ αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in naive thymus-derived CD8+ αβ T cells listed in PINNACLE. For this overlapping set, calculate the average embedding to serve as a reference, and then compute the cosine similarity between the reference and each individual target's embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['MT-ND3', 'GRAMD2A', 'ZNF829', 'STAB2', 'C10orf120']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,MT-ND3,"Among the genes MT-ND3, GRAMD2A, ZNF829, STAB2, and C10orf120, which one demonstrates the greatest cell type–specific expression in naive thymus-derived CD8-positive alpha-beta T cells and presents the most promising candidate for targeted intervention in follicular lymphoma?","Among the genes MT-ND3, GRAMD2A, ZNF829, STAB2, and C10orf120, which one demonstrates the greatest cell type–specific expression in naive thymus-derived CD8-positive alpha-beta T cells and presents the most promising candidate for targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the naive, thymus-derived, CD8+ αβ T cell–activated genes in PINNACLE. Using this overlapping gene set, compute an average embedding as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CELF2', 'USP45', 'ASB16-AS1', 'PLCH1', 'ANXA7']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,CELF2,"Among CELF2, USP45, ASB16-AS1, PLCH1, and ANXA7, which gene displays the highest cell-type specificity in naive thymus-derived CD8-positive αβ T cells, making it the most suitable candidate for targeting follicular lymphoma?","Among CELF2, USP45, ASB16-AS1, PLCH1, and ANXA7, which gene displays the highest cell-type specificity in naive thymus-derived CD8-positive αβ T cells, making it the most suitable candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embedding data from PINNACLE. From these, determine the overlap with the naive, thymus-derived CD8-positive αβ T cell–activated genes in PINNACLE to define the set of cell-type–specific targets. Calculate the average embedding for this set and then compute the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['AFG3L2', 'PDZD3', 'PCSK6', 'NDUFA4', 'RALYL']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFA4,"Among the following genes—AFG3L2, PDZD3, PCSK6, NDUFA4, and RALYL—which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the following genes—AFG3L2, PDZD3, PCSK6, NDUFA4, and RALYL—which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type specific embeddings from the PINNACLE database. Then, determine which genes from the naive thymus-derived CD8-positive αβ T cell activation profile overlap with these targets to define a set of cell-type specific follicular lymphoma targets. Compute the average embedding of this overlapping gene set as a reference and calculate the cosine similarity between this reference and each individual target gene. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in the context of follicular lymphoma."
"['HACD3', 'LINC01194', 'FXYD7', 'SELPLG', 'HSP90AA1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AA1,"Which gene—HACD3, LINC01194, FXYD7, SELPLG, or HSP90AA1—exhibits the highest cell-type specificity in naïve thymus-derived CD8+ αβ T cells, making it the most suitable candidate for targeted therapy against follicular lymphoma?","Which gene—HACD3, LINC01194, FXYD7, SELPLG, or HSP90AA1—exhibits the highest cell-type specificity in naïve thymus-derived CD8+ αβ T cells, making it the most suitable candidate for targeted therapy against follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma using PINNACLE and extract their cell-type–specific embeddings. Next, from PINNACLE, obtain the list of genes associated with naive thymus-derived CD8+ αβ T cell activation and determine their overlap with the follicular lymphoma targets. For this overlapping set, compute the average embedding to serve as a reference vector, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PKHD1', 'MYH9', 'MEOX1', 'FAM47B', 'FYN']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,FYN,"Among the candidate genes PKHD1, MYH9, MEOX1, FAM47B, and FYN, which one demonstrates the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for potential targeting of follicular lymphoma?","Among the candidate genes PKHD1, MYH9, MEOX1, FAM47B, and FYN, which one demonstrates the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for potential targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes associated with naive thymus-derived CD8-positive alpha-beta T cell activation in PINNACLE overlap with these targets. Calculate the average embedding for the overlapping genes and compute the cosine similarity between this average and each individual embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NDUFB4', 'CCDC42', 'CDR2', 'SLC22A11', 'POLN']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFB4,"Which gene among NDUFB4, CCDC42, CDR2, SLC22A11, and POLN displays the highest specificity for naive thymus-derived CD8+ alpha-beta T cells, thereby serving as the most promising target for follicular lymphoma?","Which gene among NDUFB4, CCDC42, CDR2, SLC22A11, and POLN displays the highest specificity for naive thymus-derived CD8+ alpha-beta T cells, thereby serving as the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the gene set representing naive thymus-derived CD8-positive alpha-beta T cell activation in PINNACLE. Using the overlapping genes as your cell-type–specific targets, compute their average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND4L', 'PCNX1', 'GMPR2', 'FAM118A', 'DDX21']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,MT-ND4L,"Which gene among MT-ND4L, PCNX1, GMPR2, FAM118A, and DDX21 exhibits the highest specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among MT-ND4L, PCNX1, GMPR2, FAM118A, and DDX21 exhibits the highest specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus-derived CD8-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set to create a reference vector, then compute the cosine similarity between this reference and each individual target gene embedding. If one gene exhibits a markedly higher similarity than all others, nominate it as the top candidate, and provide a concise evidence-based explanation of its biological relevance."
"['SLC6A15', 'NRCAM', 'AVPR1B', 'NDUFS5', 'ATP6V0B']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFS5,"Which gene among SLC6A15, NRCAM, AVPR1B, NDUFS5, and ATP6V0B exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among SLC6A15, NRCAM, AVPR1B, NDUFS5, and ATP6V0B exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific gene embeddings from the PINNACLE database. Next, determine which of these targets overlap with the naive, thymus-derived, CD8-positive alpha-beta T cell activation gene set in PINNACLE. Calculate the average embedding of this overlapping gene set and compute the cosine similarity between this average and the embedding of each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HSP90AB1', 'PUS7', 'PRPF4', 'ERI3', 'TRAF1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AB1,"Which gene among HSP90AB1, PUS7, PRPF4, ERI3, and TRAF1 exhibits the greatest cell-type specificity in naive, thymus-derived CD8+ αβ T cells and shows the most promise as a target in follicular lymphoma?","Which gene among HSP90AB1, PUS7, PRPF4, ERI3, and TRAF1 exhibits the greatest cell-type specificity in naive, thymus-derived CD8+ αβ T cells and shows the most promise as a target in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in naive thymus-derived CD8-positive alpha-beta T cells included in PINNACLE. Using the overlapping set as cell-type–specific targets for follicular lymphoma, compute their average embedding as a reference and then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FZD6', 'TNMD', 'TTN', 'FYN', 'RPS11']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,FYN,"Which gene among FZD6, TNMD, TTN, FYN, and RPS11 demonstrates the highest specificity for naive, thymus-derived CD8+ αβ T cells in the context of targeting follicular lymphoma?","Which gene among FZD6, TNMD, TTN, FYN, and RPS11 demonstrates the highest specificity for naive, thymus-derived CD8+ αβ T cells in the context of targeting follicular lymphoma? Using the PINNACLE dataset, first identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Then, find the overlapping genes between these targets and the naive thymus–derived, CD8-positive alpha-beta T cell–activated genes in PINNACLE to define the cell-type–specific targets. Calculate the average embedding of this overlapping set to serve as a reference, and compute the cosine similarity between this reference and each individual target. Finally, if one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAP3K14', 'CA8', 'EXOSC6', 'MT-ND3', 'APEX2']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,MT-ND3,"Among MAP3K14, CA8, EXOSC6, MT-ND3, and APEX2, which gene exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among MAP3K14, CA8, EXOSC6, MT-ND3, and APEX2, which gene exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes in PINNACLE derived from naive, thymus-derived, CD8-positive, αβ T cell activation overlap with these targets to define cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set, then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CCR2', 'EPOR', 'MCF2L2', 'HSP90AA1', 'TEP1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AA1,"Among the genes CCR2, EPOR, MCF2L2, HSP90AA1, and TEP1, which exhibits the highest cell-type specificity in naive, thymus-derived CD8+ alpha-beta T cells for targeted therapeutic application in follicular lymphoma?","Among the genes CCR2, EPOR, MCF2L2, HSP90AA1, and TEP1, which exhibits the highest cell-type specificity in naive, thymus-derived CD8+ alpha-beta T cells for targeted therapeutic application in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of naive thymus-derived CD8-positive alpha-beta T cell-activated genes available in PINNACLE, defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB10', 'ABCE1', 'CELF1', 'FMNL3', 'SULT1B1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFB10,"Which gene among NDUFB10, ABCE1, CELF1, FMNL3, and SULT1B1 exhibits the greatest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among NDUFB10, ABCE1, CELF1, FMNL3, and SULT1B1 exhibits the greatest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma using PINNACLE and retrieve their cell-type–specific embeddings. Next, determine the overlap between these targets and the naive thymus-derived CD8+ alpha-beta T cell-activated genes from PINNACLE. For the overlapping set, calculate the average embedding to serve as a reference, then compute the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['SPAG5', 'LRRC47', 'GMFG', 'TUBB', 'ASB9']",follicular lymphoma,effector cd8-positive alpha-beta t cell,TUBB,"Among SPAG5, LRRC47, GMFG, TUBB, and ASB9, which gene exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Among SPAG5, LRRC47, GMFG, TUBB, and ASB9, which gene exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Retrieve the validated therapeutic targets for follicular lymphoma from the PINNACLE database along with their cell-type–specific embeddings. Next, identify the overlapping set between these targets and the subset of effector CD8-positive αβ T cell–activated genes from PINNACLE; these overlapping genes represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BRMS1L', 'CPLX3', 'LSM11', 'LCK', 'INSYN2A']",follicular lymphoma,effector cd8-positive alpha-beta t cell,LCK,"Which gene among BRMS1L, CPLX3, LSM11, LCK, and INSYN2A exhibits the greatest cell-type specificity in effector CD8-positive αβ T cells involved in targeting follicular lymphoma?","Which gene among BRMS1L, CPLX3, LSM11, LCK, and INSYN2A exhibits the greatest cell-type specificity in effector CD8-positive αβ T cells involved in targeting follicular lymphoma? Identify all validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from the PINNACLE dataset. Next, determine the intersection between these targets and the set of effector CD8⁺ αβ T cell-activated genes in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual target embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['LEPROTL1', 'ANKRD1', 'NINJ1', 'IL6', 'NDUFB9']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB9,"Among the genes LEPROTL1, ANKRD1, NINJ1, IL6, and NDUFB9, which one exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Among the genes LEPROTL1, ANKRD1, NINJ1, IL6, and NDUFB9, which one exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the effector CD8+ αβ T cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one target displays a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GAS8', 'FAM124A', 'LAX1', 'DNMT1', 'PPEF1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,DNMT1,"Which gene among GAS8, FAM124A, LAX1, DNMT1, and PPEF1 exhibits the highest cell-type specificity in CD8-positive effector αβ T cells for targeting follicular lymphoma?","Which gene among GAS8, FAM124A, LAX1, DNMT1, and PPEF1 exhibits the highest cell-type specificity in CD8-positive effector αβ T cells for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine the overlap between these targets and the effector CD8+ αβ T cell–activated genes present in PINNACLE. Calculate the average embedding of the overlapping set as a reference and compute the cosine similarity between this reference and each individual target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MCL1', 'MSL1', 'PROS1', 'SYT8', 'SCCPDH']",follicular lymphoma,effector cd8-positive alpha-beta t cell,MCL1,"Among the genes MCL1, MSL1, PROS1, SYT8, and SCCPDH, which one exhibits the highest specificity in effector CD8⁺ αβ T cells for follicular lymphoma targeting?","Among the genes MCL1, MSL1, PROS1, SYT8, and SCCPDH, which one exhibits the highest specificity in effector CD8⁺ αβ T cells for follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma from PINNACLE by retrieving their cell-type–specific embeddings. Then, determine the overlap between these targets and the effector CD8-positive alpha-beta T cell-activated genes in PINNACLE to define the follicular lymphoma-specific target set. Compute the average embedding of this set, calculate the cosine similarity between the average and each individual target, and, if one gene shows a markedly higher similarity than all others, nominate it as the top candidate. Provide a concise, evidence-based rationale for its biological relevance."
"['BTAF1', 'HSP90AA1', 'ABCA2', 'CARS1', 'IFT81']",follicular lymphoma,effector cd8-positive alpha-beta t cell,HSP90AA1,"Which gene among BTAF1, HSP90AA1, ABCA2, CARS1, and IFT81 exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among BTAF1, HSP90AA1, ABCA2, CARS1, and IFT81 exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD8-positive alpha-beta T cell–activated genes in PINNACLE to establish a list of cell-type–specific targets. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this reference embedding and each individual target. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC00265', 'NDUFB2', 'GRIN3B', 'IFIH1', 'NOX1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB2,"Which gene among LINC00265, NDUFB2, GRIN3B, IFIH1, and NOX1 exhibits the highest cell-type specificity in effector CD8-positive αβ T cells for targeting follicular lymphoma?","Which gene among LINC00265, NDUFB2, GRIN3B, IFIH1, and NOX1 exhibits the highest cell-type specificity in effector CD8-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma in PINNACLE and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with the gene set associated with effector CD8-positive alpha-beta T cell activation in PINNACLE. For this overlapping set, compute the average embedding and then calculate the cosine similarity between this average embedding and each individual gene's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SNRPA', 'RPL32', 'SNAPC2', 'HLCS', 'JAK1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,JAK1,"Which gene among SNRPA, RPL32, SNAPC2, HLCS, and JAK1 exhibits the highest specificity for effector CD8⁺ αβ T cells, making it the most suitable candidate for targeted intervention in follicular lymphoma?","Which gene among SNRPA, RPL32, SNAPC2, HLCS, and JAK1 exhibits the highest specificity for effector CD8⁺ αβ T cells, making it the most suitable candidate for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of effector CD8-positive alpha-beta T cell–activated genes in PINNACLE. This overlapping set will define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this set and then compute the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MT-ND4', 'NAF1', 'PPM1E', 'APOC2', 'NUTM2F']",follicular lymphoma,effector cd8-positive alpha-beta t cell,MT-ND4,"Which gene among MT-ND4, NAF1, PPM1E, APOC2, and NUTM2F exhibits the most specific expression in effector CD8+ αβ T cells for potential targeting of follicular lymphoma?","Which gene among MT-ND4, NAF1, PPM1E, APOC2, and NUTM2F exhibits the most specific expression in effector CD8+ αβ T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of effector CD8-positive αβ T cell–activated genes in PINNACLE, defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set, then compute the cosine similarity between this reference and each individual target. If one gene stands out with a markedly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-DRB5', 'ZNF683', 'UNC45B', 'ZNF432', 'ZFYVE19']",follicular lymphoma,effector cd8-positive alpha-beta t cell,HLA-DRB5,"Which gene—HLA-DRB5, ZNF683, UNC45B, ZNF432, or ZFYVE19—exhibits the most specific expression in effector CD8+ αβ T cells, making it the prime candidate for targeting follicular lymphoma?","Which gene—HLA-DRB5, ZNF683, UNC45B, ZNF432, or ZFYVE19—exhibits the most specific expression in effector CD8+ αβ T cells, making it the prime candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the effector CD8-positive αβ T cell activation genes in PINNACLE overlap with these targets, forming a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MPC2', 'NPTX1', 'SRSF10', 'MT-ND2', 'MSRB2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,MT-ND2,"Which gene among MPC2, NPTX1, SRSF10, MT-ND2, and MSRB2 exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among MPC2, NPTX1, SRSF10, MT-ND2, and MSRB2 exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes among the effector CD8-positive αβ T cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping targets and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYBL1', 'GPR26', 'IL4R', 'POLD4', 'EXOSC6']",follicular lymphoma,effector cd8-positive alpha-beta t cell,POLD4,"Among the genes MYBL1, GPR26, IL4R, POLD4, and EXOSC6, which one exhibits the highest specificity in effector CD8+ αβ T cells, thereby making it the most promising candidate for targeting follicular lymphoma?","Among the genes MYBL1, GPR26, IL4R, POLD4, and EXOSC6, which one exhibits the highest specificity in effector CD8+ αβ T cells, thereby making it the most promising candidate for targeting follicular lymphoma? Retrieve the cell-type-specific embeddings for verified therapeutic targets of follicular lymphoma from PINNACLE. Next, identify the overlapping genes between these targets and the effector CD8⁺ αβ T cell-activated genes in PINNACLE, which represent the cell-type-specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a considerably higher similarity score compared to the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ATP5MF', 'APOOL', 'CFAP57', 'NDUFA1', 'RHOF']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFA1,"Which gene among ATP5MF, APOOL, CFAP57, NDUFA1, and RHOF exhibits the most specific expression in effector CD8+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among ATP5MF, APOOL, CFAP57, NDUFA1, and RHOF exhibits the most specific expression in effector CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the effector CD8-positive αβ T cell–activated genes in PINNACLE. Compute the average embedding for the overlapping genes, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFAB1', 'FAM168B', 'BPIFB3', 'ARNT2', 'PMS2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFAB1,"Among NDUFAB1, FAM168B, BPIFB3, ARNT2, and PMS2, which gene exhibits the most specific expression in CD8+ effector alpha-beta T cells, thereby representing the best candidate target for follicular lymphoma treatment?","Among NDUFAB1, FAM168B, BPIFB3, ARNT2, and PMS2, which gene exhibits the most specific expression in CD8+ effector alpha-beta T cells, thereby representing the best candidate target for follicular lymphoma treatment? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the effector CD8-positive alpha-beta T cell activation gene set in PINNACLE. For the overlapping genes, compute the average embedding and then calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRUNE2', 'GLYCTK', 'NT5C1B', 'SNRPB2', 'NDUFV2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFV2,"Among the genes PRUNE2, GLYCTK, NT5C1B, SNRPB2, and NDUFV2, which demonstrates the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Among the genes PRUNE2, GLYCTK, NT5C1B, SNRPB2, and NDUFV2, which demonstrates the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the effector CD8-positive αβ T cell–activated gene set in PINNACLE. Calculate the average embedding of the overlapping genes as a reference profile, then compute the cosine similarity between this reference and each individual target. If one target shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB11', 'UPK1A', 'EXT2', 'EIF2D', 'SLC25A1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB11,"Which gene among NDUFB11, UPK1A, EXT2, EIF2D, and SLC25A1 exhibits the highest cell-type specificity in effector CD8+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among NDUFB11, UPK1A, EXT2, EIF2D, and SLC25A1 exhibits the highest cell-type specificity in effector CD8+ alpha-beta T cells for targeting follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the set of effector CD8+ alpha-beta T cell–activated genes available in PINNACLE; this intersection represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['G6PC1', 'NCAPD2', 'E2F3', 'PIK3R1', 'TJP2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,PIK3R1,"Which gene among G6PC1, NCAPD2, E2F3, PIK3R1, and TJP2 exhibits the highest cell-type specificity in effector CD8⁺ αβ T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among G6PC1, NCAPD2, E2F3, PIK3R1, and TJP2 exhibits the highest cell-type specificity in effector CD8⁺ αβ T cells, making it the optimal candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which of the PINNACLE-associated effector CD8+ alpha-beta T cell-activated genes overlap with these targets. Using this overlapping set, compute the average embedding as a reference and evaluate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CXCR4', 'ZNF385A', 'ETAA1', 'HAND1', 'ARSJ']",follicular lymphoma,effector cd8-positive alpha-beta t cell,CXCR4,"Among the genes CXCR4, ZNF385A, ETAA1, HAND1, and ARSJ, which one shows the highest cell-type specificity in effector CD8+ alpha-beta T cells for targeting follicular lymphoma?","Among the genes CXCR4, ZNF385A, ETAA1, HAND1, and ARSJ, which one shows the highest cell-type specificity in effector CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes associated with activated effector CD8-positive alpha-beta T cells in PINNACLE to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CRBN', 'KCTD16', 'MCCC2', 'INO80C', 'THAP6']",follicular lymphoma,effector cd8-positive alpha-beta t cell,CRBN,"Which gene—CRBN, KCTD16, MCCC2, INO80C, or THAP6—exhibits the highest cell-type specificity in effector CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene—CRBN, KCTD16, MCCC2, INO80C, or THAP6—exhibits the highest cell-type specificity in effector CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the effector CD8-positive alpha-beta T cell-activated genes in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NBN', 'EIF1', 'MED6', 'CMTM2', 'CDK4']",follicular lymphoma,effector cd8-positive alpha-beta t cell,CDK4,"Among the genes NBN, EIF1, MED6, CMTM2, and CDK4, which shows the greatest specificity for effector CD8-positive alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes NBN, EIF1, MED6, CMTM2, and CDK4, which shows the greatest specificity for effector CD8-positive alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in effector CD8-positive αβ T cells available in PINNACLE. Compute the average embedding of the overlapping gene set as a reference profile, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['MT-ND2', 'TJAP1', 'BTLA', 'DSG1', 'HNRNPDL']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND2,"Which gene among MT-ND2, TJAP1, BTLA, DSG1, and HNRNPDL exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene among MT-ND2, TJAP1, BTLA, DSG1, and HNRNPDL exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes associated with activated CD8-positive alpha-beta T cells in PINNACLE. Compute the average embedding of the overlapping set and then calculate the cosine similarity between this average and each individual target's embedding. If one gene has a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA6', 'C3orf56', 'LRP8', 'PACS1', 'ENPP2']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFA6,"Which gene—NDUFA6, C3orf56, LRP8, PACS1, or ENPP2—exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene—NDUFA6, C3orf56, LRP8, PACS1, or ENPP2—exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the cd8-positive alpha-beta T cell-activated genes from PINNACLE. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['GAS2L3', 'THEMIS2', 'RRM1', 'AATK', 'NPHP3']",follicular lymphoma,cd8-positive alpha-beta t cell,RRM1,"Which gene, among GAS2L3, THEMIS2, RRM1, AATK, and NPHP3, exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for potential targeting in follicular lymphoma?","Which gene, among GAS2L3, THEMIS2, RRM1, AATK, and NPHP3, exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for potential targeting in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the CD8-positive αβ T cell-activated genes in PINNACLE. Compute the average embedding of the overlapping genes as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['JTB', 'AKR1A1', 'MSTO1', 'CDK1', 'HMG20A']",follicular lymphoma,cd8-positive alpha-beta t cell,CDK1,"Among the genes JTB, AKR1A1, MSTO1, CDK1, and HMG20A, which shows the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Among the genes JTB, AKR1A1, MSTO1, CDK1, and HMG20A, which shows the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma? Which verified therapeutic targets for follicular lymphoma have corresponding cell-type-specific embeddings in PINNACLE that overlap with cd8-positive alpha-beta T cell-activated genes? Calculate the average embedding of these overlapping genes as a reference and then determine the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['S1PR2', 'NTSR2', 'HDAC2', 'C1QTNF5', 'TUT1']",follicular lymphoma,cd8-positive alpha-beta t cell,HDAC2,"Which gene among S1PR2, NTSR2, HDAC2, C1QTNF5, and TUT1 exhibits the highest specificity in CD8-positive alpha-beta T cells as a potential target for follicular lymphoma?","Which gene among S1PR2, NTSR2, HDAC2, C1QTNF5, and TUT1 exhibits the highest specificity in CD8-positive alpha-beta T cells as a potential target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma by obtaining their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and CD8-positive αβ T cell–activated genes in PINNACLE, forming the cell-type–specific target set for follicular lymphoma. Calculate the average embedding vector for this overlapping set and then compute the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EZH2', 'ARHGEF25', 'TBC1D3B', 'RNF24', 'VAX1']",follicular lymphoma,cd8-positive alpha-beta t cell,EZH2,"Among the genes EZH2, ARHGEF25, TBC1D3B, RNF24, and VAX1, which exhibits the highest cell-type specificity in CD8+ alpha-beta T cells for targeting follicular lymphoma?","Among the genes EZH2, ARHGEF25, TBC1D3B, RNF24, and VAX1, which exhibits the highest cell-type specificity in CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which cd8-positive αβ T cell–activated genes in PINNACLE are also among these targets. Using this overlapping gene set, calculate the average embedding as a reference vector and then compute the cosine similarity between the reference and each individual target gene embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPINK2', 'TWNK', 'BEX2', 'IFNAR2', 'EGFR']",follicular lymphoma,cd8-positive alpha-beta t cell,IFNAR2,"Among SPINK2, TWNK, BEX2, IFNAR2, and EGFR, which gene demonstrates the highest specificity to CD8-positive αβ T cells for potential targeting of follicular lymphoma?","Among SPINK2, TWNK, BEX2, IFNAR2, and EGFR, which gene demonstrates the highest specificity to CD8-positive αβ T cells for potential targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which CD8-positive αβ T cell activated genes within PINNACLE overlap with these targets. Calculate the average embedding of the overlapping genes as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['POLA1', 'POLR3F', 'NFAM1', 'CNIH2', 'EEF1DP3']",follicular lymphoma,cd8-positive alpha-beta t cell,POLA1,"Which gene—POLA1, POLR3F, NFAM1, CNIH2, or EEF1DP3—demonstrates the highest cell-type specificity in CD8-positive αβ T cells, thereby representing the most suitable candidate for targeting follicular lymphoma?","Which gene—POLA1, POLR3F, NFAM1, CNIH2, or EEF1DP3—demonstrates the highest cell-type specificity in CD8-positive αβ T cells, thereby representing the most suitable candidate for targeting follicular lymphoma? What are the validated therapeutic targets for follicular lymphoma, and what are their corresponding cell-type–specific embeddings in PINNACLE? Identify the overlap between these targets and the CD8-positive αβ T cell–activated genes in PINNACLE. Next, compute the average embedding of the overlapping gene set and calculate the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CNIH3', 'IMPDH1', 'TRBV2', 'UTF1', 'CLEC4A']",follicular lymphoma,cd8-positive alpha-beta t cell,IMPDH1,"Among the genes CNIH3, IMPDH1, TRBV2, UTF1, and CLEC4A, which one exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Among the genes CNIH3, IMPDH1, TRBV2, UTF1, and CLEC4A, which one exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the cd8-positive alpha-beta T cell activation genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding of this set and then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SVOP', 'ABCG5', 'MGAT5B', 'MT-ND1', 'BLZF1']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND1,"Which gene among SVOP, ABCG5, MGAT5B, MT-ND1, and BLZF1 exhibits the highest expression specificity in CD8-positive αβ T cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Which gene among SVOP, ABCG5, MGAT5B, MT-ND1, and BLZF1 exhibits the highest expression specificity in CD8-positive αβ T cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify and retrieve the verified therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings from PINNACLE. Next, determine which of these overlap with the cd8-positive alpha-beta T cell activation genes in PINNACLE to define a subset of cell-type–specific targets. Calculate the average embedding of this overlapping set to establish a reference, then compute the cosine similarity between this reference and each individual target embedding. If a single gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CD38', 'GNAO1', 'AMOTL2', 'GRM1', 'RACK1']",follicular lymphoma,cd8-positive alpha-beta t cell,CD38,"Which gene among CD38, GNAO1, AMOTL2, GRM1, and RACK1 exhibits the highest expression specificity in CD8-positive αβ T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among CD38, GNAO1, AMOTL2, GRM1, and RACK1 exhibits the highest expression specificity in CD8-positive αβ T cells, making it the optimal candidate for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which CD8-positive αβ T cell-activated genes in PINNACLE overlap with these targets, defining a subset of cell-type–specific targets. Calculate the average embedding for this subset and compute the cosine similarity between this average and the embedding of each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDKL5', 'COPS7A', 'PTH', 'STK33', 'HLA-DRB5']",follicular lymphoma,cd8-positive alpha-beta t cell,HLA-DRB5,"Among the following genes—CDKL5, COPS7A, PTH, STK33, and HLA-DRB5—which exhibits the highest cell-type specificity in CD8+ alpha-beta T cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among the following genes—CDKL5, COPS7A, PTH, STK33, and HLA-DRB5—which exhibits the highest cell-type specificity in CD8+ alpha-beta T cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify all verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the CD8-positive αβ T cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARL4D', 'NUMA1', 'IMPDH2', 'MRPL44', 'TTF1']",follicular lymphoma,cd8-positive alpha-beta t cell,IMPDH2,"Which gene—ARL4D, NUMA1, IMPDH2, MRPL44, or TTF1—exhibits the highest cell-type specificity in CD8-positive αβ T cells for the targeted treatment of follicular lymphoma?","Which gene—ARL4D, NUMA1, IMPDH2, MRPL44, or TTF1—exhibits the highest cell-type specificity in CD8-positive αβ T cells for the targeted treatment of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type-specific embeddings from PINNACLE. Next, identify which of the CD8-positive alpha-beta T cell activation genes in PINNACLE overlap with these targets to define the cell-type-specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CYP4B1', 'KRTAP4-12', 'AKAP3', 'POLD3', 'PKD2L1']",follicular lymphoma,cd8-positive alpha-beta t cell,POLD3,"Among the genes CYP4B1, KRTAP4-12, AKAP3, POLD3, and PKD2L1, which exhibits the highest specificity for CD8-positive alpha-beta T cells as a target for follicular lymphoma?","Among the genes CYP4B1, KRTAP4-12, AKAP3, POLD3, and PKD2L1, which exhibits the highest specificity for CD8-positive alpha-beta T cells as a target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of activated genes from CD8-positive alpha-beta T cells in PINNACLE. Compute the average embedding of this overlapping set and calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['RHEB', 'SDHAF3', 'SERTAD4', 'NDUFS2', 'CYGB']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFS2,"Among the following genes—RHEB, SDHAF3, SERTAD4, NDUFS2, and CYGB—which one shows the highest cell-type specificity in CD8+ αβ T cells for potential targeting of follicular lymphoma?","Among the following genes—RHEB, SDHAF3, SERTAD4, NDUFS2, and CYGB—which one shows the highest cell-type specificity in CD8+ αβ T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the cd8-positive alpha-beta T cell-activated genes available in PINNACLE, as this overlapping group defines the cell-type-specific targets of interest. Compute the average embedding for this group and then calculate the cosine similarity between this average and the embedding of each individual target. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PACRGL', 'NDUFAF4', 'GBP5', 'PPP2R2D', 'HTR4']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFAF4,"Among the genes PACRGL, NDUFAF4, GBP5, PPP2R2D, and HTR4, which one exhibits the highest cell-type–specific expression in CD8+ alpha-beta T cells relevant to follicular lymphoma targeting?","Among the genes PACRGL, NDUFAF4, GBP5, PPP2R2D, and HTR4, which one exhibits the highest cell-type–specific expression in CD8+ alpha-beta T cells relevant to follicular lymphoma targeting? Using the PINNACLE database, identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings. Next, determine the intersection between these targets and the genes activated in CD8+ alpha-beta T cells. Compute the average embedding for the overlapping genes, and then calculate the cosine similarity between this average embedding and each individual gene in the overlap. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation of its biological significance."
"['CUL4A', 'SPATA5L1', 'KLF17', 'ACTR3B', 'SCAI']",follicular lymphoma,cd8-positive alpha-beta t cell,CUL4A,"Which gene among CUL4A, SPATA5L1, KLF17, ACTR3B, and SCAI shows the highest cell-type specificity in CD8-positive αβ T cells, indicating its potential as a targeted approach for follicular lymphoma?","Which gene among CUL4A, SPATA5L1, KLF17, ACTR3B, and SCAI shows the highest cell-type specificity in CD8-positive αβ T cells, indicating its potential as a targeted approach for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the cd8-positive alpha-beta T cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLA2', 'EHMT2', 'MPG', 'RAB14', 'CCDC130']",follicular lymphoma,cd8-positive alpha-beta t cell,POLA2,"Which gene among POLA2, EHMT2, MPG, RAB14, and CCDC130 exhibits the highest cell-type specificity in CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among POLA2, EHMT2, MPG, RAB14, and CCDC130 exhibits the highest cell-type specificity in CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which CD8-positive alpha-beta T cell activation genes in PINNACLE overlap with these targets. Calculate the average embedding for the overlapping set and compute the cosine similarity between this average and the embedding for each gene. If one gene shows a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SLC2A6', 'TICAM2', 'LUC7L', 'UQCRQ', 'TNFRSF9']",follicular lymphoma,cd8-positive alpha-beta t cell,TNFRSF9,"Which gene among SLC2A6, TICAM2, LUC7L, UQCRQ, and TNFRSF9 exhibits the highest specificity in CD8-positive αβ T cells for the targeted treatment of follicular lymphoma?","Which gene among SLC2A6, TICAM2, LUC7L, UQCRQ, and TNFRSF9 exhibits the highest specificity in CD8-positive αβ T cells for the targeted treatment of follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma from the PINNACLE dataset and extract their cell-type–specific embeddings. Next, determine which CD8+ alpha-beta T cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAPK6', 'GPR50', 'NDUFC1', 'TEKT2', 'RBM14']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFC1,"Which gene among MAPK6, GPR50, NDUFC1, TEKT2, and RBM14 exhibits the highest specificity for CD8-positive αβ T cells as a potential target in follicular lymphoma?","Which gene among MAPK6, GPR50, NDUFC1, TEKT2, and RBM14 exhibits the highest specificity for CD8-positive αβ T cells as a potential target in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which of the CD8-positive αβ T cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IVNS1ABP', 'GOLGA3', 'CLEC19A', 'IL6R', 'DEDD2']",follicular lymphoma,t follicular helper cell,IL6R,"Which gene among IVNS1ABP, GOLGA3, CLEC19A, IL6R, and DEDD2 exhibits the highest cell-type specificity in follicular helper T cells, making it the most promising candidate target for follicular lymphoma?","Which gene among IVNS1ABP, GOLGA3, CLEC19A, IL6R, and DEDD2 exhibits the highest cell-type specificity in follicular helper T cells, making it the most promising candidate target for follicular lymphoma? Which verified therapeutic targets for follicular lymphoma share cell-type–specific embeddings with t follicular helper cell-activated genes in PINNACLE? Retrieve the relevant embeddings, calculate their average to serve as a reference vector, and then determine the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CCDC198', 'FERMT2', 'RHOU', 'NDUFB7', 'PRDM4']",follicular lymphoma,t follicular helper cell,NDUFB7,"Which gene among CCDC198, FERMT2, RHOU, NDUFB7, and PRDM4 exhibits the highest specificity in T follicular helper cells for targeting follicular lymphoma?","Which gene among CCDC198, FERMT2, RHOU, NDUFB7, and PRDM4 exhibits the highest specificity in T follicular helper cells for targeting follicular lymphoma? Using verified therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the set of t follicular helper cell–activated genes in PINNACLE; this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these genes and calculate the cosine similarity between this average and each gene’s individual embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['EPHB3', 'HDAC3', 'DLL3', 'NAA30', 'CENPK']",follicular lymphoma,t follicular helper cell,HDAC3,"Among the genes EPHB3, HDAC3, DLL3, NAA30, and CENPK, which one exhibits the highest specificity to T follicular helper cells and is therefore the most promising candidate for targeted follicular lymphoma therapy?","Among the genes EPHB3, HDAC3, DLL3, NAA30, and CENPK, which one exhibits the highest specificity to T follicular helper cells and is therefore the most promising candidate for targeted follicular lymphoma therapy? Identify the experimentally validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which t follicular helper cell–activated genes in PINNACLE overlap with these targets. For the overlapping set, calculate the average embedding and compute the cosine similarity of each individual target to this reference. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['DNMT1', 'ARPC2', 'CDH5', 'REM1', 'SLC35E1']",follicular lymphoma,t follicular helper cell,DNMT1,"Which gene among DNMT1, ARPC2, CDH5, REM1, and SLC35E1 exhibits the highest specificity of expression in T follicular helper cells, thereby representing the most promising candidate for targeting follicular lymphoma?","Which gene among DNMT1, ARPC2, CDH5, REM1, and SLC35E1 exhibits the highest specificity of expression in T follicular helper cells, thereby representing the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the t follicular helper cell-activated genes listed in PINNACLE. These overlapping genes represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual gene's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SUCLG2', 'KRTAP3-3', 'IFNAR1', 'HRH4', 'FCHSD1']",follicular lymphoma,t follicular helper cell,IFNAR1,"Among the genes SUCLG2, KRTAP3-3, IFNAR1, HRH4, and FCHSD1, which one demonstrates the highest cell-type specificity in T follicular helper cells relevant to targeting follicular lymphoma?","Among the genes SUCLG2, KRTAP3-3, IFNAR1, HRH4, and FCHSD1, which one demonstrates the highest cell-type specificity in T follicular helper cells relevant to targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in t follicular helper cells. For the overlapping set, compute the average embedding as a reference and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ABCB11', 'CDK4', 'FSD1', 'HTR2A', 'NINJ2']",follicular lymphoma,t follicular helper cell,CDK4,"Which gene among ABCB11, CDK4, FSD1, HTR2A, and NINJ2 exhibits the highest specificity for T follicular helper cells, making it the most promising candidate for targeted intervention in follicular lymphoma?","Which gene among ABCB11, CDK4, FSD1, HTR2A, and NINJ2 exhibits the highest specificity for T follicular helper cells, making it the most promising candidate for targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which t follicular helper cell-activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping gene set and compute the cosine similarity between this average and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['GP6', 'NDUFB9', 'RNF111', 'HAPLN2', 'PAQR8']",follicular lymphoma,t follicular helper cell,NDUFB9,"Which gene among GP6, NDUFB9, RNF111, HAPLN2, and PAQR8 exhibits the highest specificity in T follicular helper cells as a potential target for follicular lymphoma?","Which gene among GP6, NDUFB9, RNF111, HAPLN2, and PAQR8 exhibits the highest specificity in T follicular helper cells as a potential target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, cross-reference these targets with the T follicular helper cell–activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference embedding and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['HSP90AA1', 'CCN4', 'PTAFR', 'PPY', 'DNAJB11']",follicular lymphoma,t follicular helper cell,HSP90AA1,"Which gene among HSP90AA1, CCN4, PTAFR, PPY, and DNAJB11 exhibits the highest specificity for T follicular helper cells in the context of targeting follicular lymphoma?","Which gene among HSP90AA1, CCN4, PTAFR, PPY, and DNAJB11 exhibits the highest specificity for T follicular helper cells in the context of targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma using cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and t follicular helper cell-activated genes in PINNACLE. For the overlapping genes, compute the average embedding and then calculate the cosine similarity between this average and each individual gene’s embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance in follicular lymphoma."
"['NDUFS2', 'WNT11', 'IL1A', 'NR1H2', 'SARDH']",follicular lymphoma,t follicular helper cell,NDUFS2,"Among the genes NDUFS2, WNT11, IL1A, NR1H2, and SARDH, which one demonstrates the highest cell-type specificity in T follicular helper cells, making it the most promising target for follicular lymphoma therapy?","Among the genes NDUFS2, WNT11, IL1A, NR1H2, and SARDH, which one demonstrates the highest cell-type specificity in T follicular helper cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the t follicular helper cell–activated genes in PINNACLE also serve as targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and the embedding of each target. If one gene exhibits substantially higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFV3', 'RFC1', 'CEP44', 'COMMD5', 'CEBPB']",follicular lymphoma,t follicular helper cell,NDUFV3,"Which gene among NDUFV3, RFC1, CEP44, COMMD5, and CEBPB exhibits the most specific expression in T follicular helper cells, making it the best candidate for targeted intervention in follicular lymphoma?","Which gene among NDUFV3, RFC1, CEP44, COMMD5, and CEBPB exhibits the most specific expression in T follicular helper cells, making it the best candidate for targeted intervention in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with t follicular helper cell-activated genes in PINNACLE. Using the overlapping set as the cell-type-specific targets for follicular lymphoma, compute their average embedding as a reference, and then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['MPRIP', 'SLC2A4', 'TUBB4B', 'SDHAF2', 'UBE2R2']",follicular lymphoma,t follicular helper cell,TUBB4B,"Among the following genes—MPRIP, SLC2A4, TUBB4B, SDHAF2, and UBE2R2—which one exhibits the highest specificity for T follicular helper cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the following genes—MPRIP, SLC2A4, TUBB4B, SDHAF2, and UBE2R2—which one exhibits the highest specificity for T follicular helper cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and genes activated in T follicular helper cells within PINNACLE to define follicular lymphoma cell-type-specific targets. Calculate the average embedding of these overlapping genes as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RLN3', 'TRMT12', 'NDUFB4', 'VPS13C', 'MAFK']",follicular lymphoma,t follicular helper cell,NDUFB4,"Which gene among RLN3, TRMT12, NDUFB4, VPS13C, and MAFK exhibits the highest specificity for T follicular helper cells, thereby representing the best candidate for targeted therapy in follicular lymphoma?","Which gene among RLN3, TRMT12, NDUFB4, VPS13C, and MAFK exhibits the highest specificity for T follicular helper cells, thereby representing the best candidate for targeted therapy in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type specific embeddings from PINNACLE. Next, determine which of these targets overlap with t follicular helper cell–activated genes in PINNACLE. Compute the average embedding of this overlapping set and evaluate the cosine similarity between this average and each individual target embedding. Finally, determine if one gene exhibits a markedly higher similarity compared to the others, and if so, nominate it as the top candidate with a concise, evidence-based rationale for its biological relevance."
"['DUS3L', 'EIF2AK2', 'LARGE1', 'NDUFA2', 'ARFGEF3']",follicular lymphoma,t follicular helper cell,NDUFA2,"Among DUS3L, EIF2AK2, LARGE1, NDUFA2, and ARFGEF3, which gene exhibits the highest T follicular helper cell specificity in the context of targeting follicular lymphoma?","Among DUS3L, EIF2AK2, LARGE1, NDUFA2, and ARFGEF3, which gene exhibits the highest T follicular helper cell specificity in the context of targeting follicular lymphoma? Using PINNACLE, identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings. Next, determine which of these targets overlap with the genes activated in t follicular helper cells. For the overlapping genes, calculate the average embedding as a reference and then compute the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SRSF1', 'NDUFS5', 'PPP2R2A', 'TAOK3', 'UGT2B7']",follicular lymphoma,t follicular helper cell,NDUFS5,"Which gene among SRSF1, NDUFS5, PPP2R2A, TAOK3, and UGT2B7 shows the most specific expression in T follicular helper cells, indicating the best candidate for targeted follicular lymphoma treatment?","Which gene among SRSF1, NDUFS5, PPP2R2A, TAOK3, and UGT2B7 shows the most specific expression in T follicular helper cells, indicating the best candidate for targeted follicular lymphoma treatment? For a set of verified therapeutic targets for follicular lymphoma, extract their cell‐type–specific embeddings from PINNACLE. Identify which of these overlap with t follicular helper cell–activated genes in PINNACLE, treating the overlap as the cell‐type–specific targets for follicular lymphoma. Compute the average embedding of this set to create a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LSM3', 'GC', 'SGCZ', 'NDUFS4', 'KLHL14']",follicular lymphoma,t follicular helper cell,NDUFS4,"Which gene among LSM3, GC, SGCZ, NDUFS4, and KLHL14 shows the most specific expression in T follicular helper cells, thus representing the best candidate for targeting follicular lymphoma?","Which gene among LSM3, GC, SGCZ, NDUFS4, and KLHL14 shows the most specific expression in T follicular helper cells, thus representing the best candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the t follicular helper cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS8', 'ACO1', 'CYBRD1', 'ADGRB1', 'G6PC1']",follicular lymphoma,t follicular helper cell,NDUFS8,"Which gene among NDUFS8, ACO1, CYBRD1, ADGRB1, and G6PC1 exhibits the highest cell-type specificity in T follicular helper cells, making it the most promising candidate for targeted intervention in follicular lymphoma?","Which gene among NDUFS8, ACO1, CYBRD1, ADGRB1, and G6PC1 exhibits the highest cell-type specificity in T follicular helper cells, making it the most promising candidate for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the t follicular helper cell–activated genes from PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this reference and each individual target’s embedding. Finally, if one gene shows a significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PEX1', 'LARGE1', 'AMPD2', 'BAMBI', 'YES1']",follicular lymphoma,t follicular helper cell,YES1,"Which gene among PEX1, LARGE1, AMPD2, BAMBI, and YES1 exhibits the highest cell-type specificity in T follicular helper cells, making it the most promising candidate for targeted intervention in follicular lymphoma?","Which gene among PEX1, LARGE1, AMPD2, BAMBI, and YES1 exhibits the highest cell-type specificity in T follicular helper cells, making it the most promising candidate for targeted intervention in follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, cross-reference these targets with t follicular helper cell–activated genes in PINNACLE to define the set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference vector, then calculate the cosine similarity between the reference and each individual target’s embedding. If one gene shows a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABRAXAS2', 'TF', 'MT-ND4', 'WDR5B', 'GH2']",follicular lymphoma,t follicular helper cell,MT-ND4,"Among the genes ABRAXAS2, TF, MT-ND4, WDR5B, and GH2, which one exhibits the greatest specificity for T follicular helper cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes ABRAXAS2, TF, MT-ND4, WDR5B, and GH2, which one exhibits the greatest specificity for T follicular helper cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Retrieve the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Identify the genes activated in t follicular helper cells within PINNACLE that overlap with these targets. For this overlapping set, calculate the average embedding to serve as a reference, then compute the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['CBARP', 'CDC14A', 'HDAC1', 'TMCC3', 'COLQ']",follicular lymphoma,t follicular helper cell,HDAC1,"Which gene among CBARP, CDC14A, HDAC1, TMCC3, and COLQ shows the highest cell-type-specific expression in T follicular helper cells, making it the most promising target for follicular lymphoma therapy?","Which gene among CBARP, CDC14A, HDAC1, TMCC3, and COLQ shows the highest cell-type-specific expression in T follicular helper cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the t follicular helper cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PSRC1', 'VPS4A', 'ADGRF4', 'NMNAT1', 'CD38']",follicular lymphoma,t follicular helper cell,CD38,"Which gene among PSRC1, VPS4A, ADGRF4, NMNAT1, and CD38 exhibits the highest cell-type specificity in T follicular helper cells, thereby representing the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among PSRC1, VPS4A, ADGRF4, NMNAT1, and CD38 exhibits the highest cell-type specificity in T follicular helper cells, thereby representing the most promising candidate for targeted therapy in follicular lymphoma? Which genes have been validated as therapeutic targets in follicular lymphoma? Retrieve their cell-type–specific embeddings from PINNACLE and determine the overlap with t follicular helper cell–activated genes in the same dataset. For the overlapping set, calculate the average embedding and then compute the cosine similarity between this reference embedding and each individual gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['FGF6', 'SMAP1', 'MCAT', 'CTNND2', 'NDUFB6']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFB6,"Which gene, among FGF6, SMAP1, MCAT, CTNND2, and NDUFB6, exhibits the highest cell-type-specific expression in CD4-positive αβ T cells for follicular lymphoma targeting?","Which gene, among FGF6, SMAP1, MCAT, CTNND2, and NDUFB6, exhibits the highest cell-type-specific expression in CD4-positive αβ T cells for follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the CD4-positive alpha-beta T cell–activated genes in PINNACLE. Compute the average embedding for the overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['MCL1', 'FAM189B', 'CCDC28A-AS1', 'COG2', 'FAM110A']",follicular lymphoma,cd4-positive alpha-beta t cell,MCL1,"Which gene among MCL1, FAM189B, CCDC28A-AS1, COG2, and FAM110A demonstrates the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene among MCL1, FAM189B, CCDC28A-AS1, COG2, and FAM110A demonstrates the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which genes from the cd4-positive alpha-beta T cell activation set in PINNACLE overlap with these targets. Calculate the mean embedding for this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['SHISA5', 'NR3C1', 'CDKL3', 'OLA1', 'GALNT15']",follicular lymphoma,cd4-positive alpha-beta t cell,NR3C1,"Among the candidate genes SHISA5, NR3C1, CDKL3, OLA1, and GALNT15, which one exhibits the highest specificity in CD4-positive αβ T cells, making it the most promising target for follicular lymphoma therapy?","Among the candidate genes SHISA5, NR3C1, CDKL3, OLA1, and GALNT15, which one exhibits the highest specificity in CD4-positive αβ T cells, making it the most promising target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and extract their cell‐type–specific embeddings from the PINNACLE database. Next, determine which of the CD4-positive alpha-beta T cell activation genes in PINNACLE overlap with these therapeutic targets to define a cell-type–specific gene set for follicular lymphoma. Calculate the average embedding vector for this overlapping set and then measure the cosine similarity between this average vector and each individual gene embedding. If one gene displays a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['STX6', 'NDUFB4', 'NELFCD', 'VTI1B', 'CCDC167']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFB4,"Among the genes STX6, NDUFB4, NELFCD, VTI1B, and CCDC167, which one shows the highest cell-type specificity in CD4-positive αβ T cells for targeting follicular lymphoma?","Among the genes STX6, NDUFB4, NELFCD, VTI1B, and CCDC167, which one shows the highest cell-type specificity in CD4-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the cd4-positive alpha-beta T cell activation genes listed in PINNACLE. Compute the average embedding of this overlapping gene set and calculate the cosine similarity between this average embedding and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['AP1G2', 'NDUFA8', 'TOX2', 'ZNF234', 'FAM217B']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFA8,"Among AP1G2, NDUFA8, TOX2, ZNF234, and FAM217B, which gene exhibits the greatest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Among AP1G2, NDUFA8, TOX2, ZNF234, and FAM217B, which gene exhibits the greatest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma? Using the PINNACLE dataset, identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings. Next, determine which of these targets overlap with the cd4-positive alpha-beta T cell-activated genes in PINNACLE to define the cell-type–specific follicular lymphoma targets. For this overlapping set, calculate the average embedding and then compute the cosine similarity between this average and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GPR50', 'CENPW', 'HDAC2', 'CRYBB2', 'MTFR1L']",follicular lymphoma,cd4-positive alpha-beta t cell,HDAC2,"Among the genes GPR50, CENPW, HDAC2, CRYBB2, and MTFR1L, which exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Among the genes GPR50, CENPW, HDAC2, CRYBB2, and MTFR1L, which exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the CD4-positive alpha-beta T cell activation genes in PINNACLE overlap with these targets to define cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and then calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TM4SF18', 'DRICH1', 'RGS17', 'ZMYM4', 'NDUFA9']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFA9,"Which gene among TM4SF18, DRICH1, RGS17, ZMYM4, and NDUFA9 exhibits the highest cell-type specific expression in CD4-positive αβ T cells, thereby representing the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among TM4SF18, DRICH1, RGS17, ZMYM4, and NDUFA9 exhibits the highest cell-type specific expression in CD4-positive αβ T cells, thereby representing the most promising candidate for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the cd4-positive alpha-beta T cell-activated genes in PINNACLE, yielding the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FUT4', 'MYLIP', 'HIRA', 'POLD2', 'SRPRB']",follicular lymphoma,cd4-positive alpha-beta t cell,POLD2,"Among the genes FUT4, MYLIP, HIRA, POLD2, and SRPRB, which one exhibits the highest cell-type specificity in CD4-positive αβ T cells for targeting follicular lymphoma?","Among the genes FUT4, MYLIP, HIRA, POLD2, and SRPRB, which one exhibits the highest cell-type specificity in CD4-positive αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the CD4-positive alpha-beta T cell activation genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate gene and provide a succinct, evidence-based explanation of its biological relevance."
"['MAOA', 'CNPY2', 'NDUFAB1', 'SNAP47', 'GFOD1']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFAB1,"Which gene among MAOA, CNPY2, NDUFAB1, SNAP47, and GFOD1 exhibits the highest specificity in CD4-positive alpha-beta T cells, making it the most promising target for follicular lymphoma therapy?","Which gene among MAOA, CNPY2, NDUFAB1, SNAP47, and GFOD1 exhibits the highest specificity in CD4-positive alpha-beta T cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma using PINNACLE and retrieve their cell-type-specific embeddings. Next, determine the overlap between these targets and the cd4-positive alpha-beta T cell activation genes in PINNACLE to define a set of candidate genes. Calculate the average embedding of this overlapping set as a reference, and then compute the cosine similarity between the reference and each individual gene. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARMC5', 'PRR23B', 'TTK', 'PAIP2B', 'TUBB4B']",follicular lymphoma,cd4-positive alpha-beta t cell,TUBB4B,"Which gene among ARMC5, PRR23B, TTK, PAIP2B, and TUBB4B demonstrates the greatest cell-type specificity in CD4⁺ αβ T cells, making it the optimal candidate for targeted follicular lymphoma intervention?","Which gene among ARMC5, PRR23B, TTK, PAIP2B, and TUBB4B demonstrates the greatest cell-type specificity in CD4⁺ αβ T cells, making it the optimal candidate for targeted follicular lymphoma intervention? Extract the cell-type–specific embeddings in PINNACLE for the verified therapeutic targets of follicular lymphoma. Next, identify the subset of these targets that overlap with the CD4-positive, alpha-beta T cell-activated genes in PINNACLE. For this overlapping set, compute an average embedding to serve as a reference, then assess the cosine similarity between this reference and each gene's embedding. If a single gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PHF3', 'SGCZ', 'BCL2A1', 'WFDC13', 'QTRT1']",follicular lymphoma,cd4-positive alpha-beta t cell,BCL2A1,"Which gene among PHF3, SGCZ, BCL2A1, WFDC13, and QTRT1 shows the highest cell-type specific expression in CD4-positive αβ T cells, making it the optimal target for follicular lymphoma therapy?","Which gene among PHF3, SGCZ, BCL2A1, WFDC13, and QTRT1 shows the highest cell-type specific expression in CD4-positive αβ T cells, making it the optimal target for follicular lymphoma therapy? Identify the confirmed therapeutic target genes for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine which CD4-positive alpha-beta T cell–activated genes in PINNACLE overlap with these targets, defining the cell-type–specific target set for follicular lymphoma. Next, compute the average embedding of this target set and calculate the cosine similarity between this reference vector and each individual gene’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDC42BPA', 'CCDC47', 'YBX1', 'SPANXN2', 'NDUFC1']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFC1,"Which gene among CDC42BPA, CCDC47, YBX1, SPANXN2, and NDUFC1 exhibits the highest specificity in CD4-positive alpha-beta T cells, making it the best candidate for targeted therapy against follicular lymphoma?","Which gene among CDC42BPA, CCDC47, YBX1, SPANXN2, and NDUFC1 exhibits the highest specificity in CD4-positive alpha-beta T cells, making it the best candidate for targeted therapy against follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in CD4-positive alpha-beta T cells in PINNACLE. For the overlapping genes, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a markedly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['RNASEH2A', 'ZMYND19', 'NDUFS2', 'RGS19', 'RASD2']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFS2,"Which gene among RNASEH2A, ZMYND19, NDUFS2, RGS19, and RASD2 exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among RNASEH2A, ZMYND19, NDUFS2, RGS19, and RASD2 exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma in the PINNACLE database and retrieve their cell-type–specific embeddings. Next, from the list of activated CD4-positive alpha-beta T cell genes in PINNACLE, determine the subset that overlaps with these targets. Calculate the average embedding of this overlapping set to serve as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EBF3', 'OGFOD3', 'HSP90AA1', 'ZNF443', 'TJP2']",follicular lymphoma,cd4-positive alpha-beta t cell,HSP90AA1,"Among the genes EBF3, OGFOD3, HSP90AA1, ZNF443, and TJP2, which exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes EBF3, OGFOD3, HSP90AA1, ZNF443, and TJP2, which exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Then, determine the overlapping set between these targets and the CD4-positive alpha-beta T cell–activated genes in PINNACLE. Compute the average embedding for this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STS', 'IL6R', 'HCCS', 'TLCD3A', 'C22orf46']",follicular lymphoma,cd4-positive alpha-beta t cell,IL6R,"Among the genes STS, IL6R, HCCS, TLCD3A, and C22orf46, which one exhibits the highest specificity for CD4+ alpha-beta T cells, thereby representing the best candidate target for follicular lymphoma therapy?","Among the genes STS, IL6R, HCCS, TLCD3A, and C22orf46, which one exhibits the highest specificity for CD4+ alpha-beta T cells, thereby representing the best candidate target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which cd4-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for this lymphoma subtype. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target’s embedding. Finally, if one gene exhibits a substantially higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC00908', 'U2AF1L5', 'CUL4A', 'KRTAP4-1', 'ASCC3']",follicular lymphoma,cd4-positive alpha-beta t cell,CUL4A,"Which gene among LINC00908, U2AF1L5, CUL4A, KRTAP4-1, and ASCC3 exhibits the highest cell-type specificity in CD4-positive αβ T cells, thereby representing the most promising candidate for follicular lymphoma targeting?","Which gene among LINC00908, U2AF1L5, CUL4A, KRTAP4-1, and ASCC3 exhibits the highest cell-type specificity in CD4-positive αβ T cells, thereby representing the most promising candidate for follicular lymphoma targeting? Using validated therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the genes activated in CD4-positive alpha-beta T cells within PINNACLE. Compute the average embedding for this overlapping set and determine the cosine similarity between this average and each individual gene embedding. If one gene shows a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HHLA3', 'OR4F16', 'EPN3', 'NDUFA12', 'XAB2']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFA12,"Which gene among HHLA3, OR4F16, EPN3, NDUFA12, and XAB2 exhibits the most cell-type–specific expression in CD4+ αβ T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among HHLA3, OR4F16, EPN3, NDUFA12, and XAB2 exhibits the most cell-type–specific expression in CD4+ αβ T cells, making it the optimal candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the cd4-positive, alpha-beta T cell activation genes in PINNACLE to establish the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set, then calculate the cosine similarity between this reference and the embedding of each target gene. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['DNMT3A', 'ZNF446', 'ZNF688', 'SIT1', 'PELP1']",follicular lymphoma,cd4-positive alpha-beta t cell,DNMT3A,"Among the genes DNMT3A, ZNF446, ZNF688, SIT1, and PELP1, which one demonstrates the highest cell-type specificity in CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes DNMT3A, ZNF446, ZNF688, SIT1, and PELP1, which one demonstrates the highest cell-type specificity in CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of the CD4-positive, αβ T cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['HTN1', 'RAC1', 'MRM3', 'NDUFS5', 'LDHAL6B']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFS5,"Which gene among HTN1, RAC1, MRM3, NDUFS5, and LDHAL6B exhibits the highest specificity in CD4-positive αβ T cells for follicular lymphoma targeting?","Which gene among HTN1, RAC1, MRM3, NDUFS5, and LDHAL6B exhibits the highest specificity in CD4-positive αβ T cells for follicular lymphoma targeting? Retrieve validated therapeutic targets for follicular lymphoma from the PINNACLE database and obtain their cell-type-specific embeddings. Next, identify which targets overlap with the set of CD4-positive alpha-beta T cell-activated genes in PINNACLE to define the cell-type-specific targets for follicular lymphoma. Calculate the average embedding of these overlapping genes and determine the cosine similarity between this reference vector and each individual target's embedding. If one gene demonstrates a substantially higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GPRC5B', 'DNAJB11', 'HDAC1', 'ESR1', 'FAM234B']",follicular lymphoma,cd4-positive alpha-beta t cell,HDAC1,"Which of the following genes—GPRC5B, DNAJB11, HDAC1, ESR1, or FAM234B—demonstrates the highest cell-type specificity in CD4+ αβ T cells for targeting follicular lymphoma?","Which of the following genes—GPRC5B, DNAJB11, HDAC1, ESR1, or FAM234B—demonstrates the highest cell-type specificity in CD4+ αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell‐type–specific embeddings from PINNACLE. Then, determine which targets overlap with the set of CD4-positive alpha-beta T cell activation genes in PINNACLE to define cell-type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes, and calculate the cosine similarity between this average and the embedding of each individual gene. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS5', 'ACYP1', 'RNF31', 'ATG4A', 'WNT6']",follicular lymphoma,regulatory t cell,NDUFS5,"Which gene among NDUFS5, ACYP1, RNF31, ATG4A, and WNT6 exhibits the most specific expression in regulatory T cells, thereby representing the optimal candidate for targeting follicular lymphoma?","Which gene among NDUFS5, ACYP1, RNF31, ATG4A, and WNT6 exhibits the most specific expression in regulatory T cells, thereby representing the optimal candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference vector, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARHGAP35', 'EPN3', 'NDUFV1', 'ATG14', 'TOPORS']",follicular lymphoma,regulatory t cell,NDUFV1,"Which gene among ARHGAP35, EPN3, NDUFV1, ATG14, and TOPORS exhibits the highest specificity for regulatory T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among ARHGAP35, EPN3, NDUFV1, ATG14, and TOPORS exhibits the highest specificity for regulatory T cells, making it the most promising candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which regulatory T cell-activated genes in PINNACLE overlap with these targets to form a set of cell-type–specific candidates. Compute the average embedding for this subset as a reference profile, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity score compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PEG3', 'IFNAR1', 'CD163', 'PIGF', 'SERPINH1']",follicular lymphoma,regulatory t cell,IFNAR1,"Which gene—PEG3, IFNAR1, CD163, PIGF, or SERPINH1—exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Which gene—PEG3, IFNAR1, CD163, PIGF, or SERPINH1—exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Which verified therapeutic targets for follicular lymphoma from PINNACLE have cell-type–specific embeddings, and which of these overlap with the set of regulatory T cell–activated genes in PINNACLE? Using these overlapping genes as the cell-type–specific targets for follicular lymphoma, compute their average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BPY2C', 'ANKRD11', 'DHX32', 'LAG3', 'DOT1L']",follicular lymphoma,regulatory t cell,LAG3,"Among the candidate genes (BPY2C, ANKRD11, DHX32, LAG3, and DOT1L), which one exhibits the highest cell-type specificity in regulatory T cells and represents the most suitable target for follicular lymphoma therapy?","Among the candidate genes (BPY2C, ANKRD11, DHX32, LAG3, and DOT1L), which one exhibits the highest cell-type specificity in regulatory T cells and represents the most suitable target for follicular lymphoma therapy? Using PINNACLE data, identify validated therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings. Next, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets. For the overlapping set, compute the average cell-type–specific embedding as a reference, then calculate the cosine similarity between this reference and each gene’s embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['IGSF1', 'TMSB4XP2', 'RGS19', 'MT-ND2', 'NUAK2']",follicular lymphoma,regulatory t cell,MT-ND2,"Which gene among IGSF1, TMSB4XP2, RGS19, MT-ND2, and NUAK2 exhibits the highest specificity for regulatory T cells in the context of follicular lymphoma targeting?","Which gene among IGSF1, TMSB4XP2, RGS19, MT-ND2, and NUAK2 exhibits the highest specificity for regulatory T cells in the context of follicular lymphoma targeting? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the regulatory T cell–activated genes in PINNACLE. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based explanation of its biological relevance."
"['PHOX2B', 'HLA-DRB1', 'SLC22A1', 'MDH1', 'STOM']",follicular lymphoma,regulatory t cell,HLA-DRB1,"Among the genes PHOX2B, HLA-DRB1, SLC22A1, MDH1, and STOM, which one displays the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Among the genes PHOX2B, HLA-DRB1, SLC22A1, MDH1, and STOM, which one displays the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Determine validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and regulatory T cell–activated genes from PINNACLE, forming a candidate set. Compute the average embedding for this set and calculate the cosine similarity between this reference and each candidate’s embedding. If one candidate displays a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DOLPP1', 'CYB561D2', 'NDUFS8', 'PGM1', 'TRAF3IP1']",follicular lymphoma,regulatory t cell,NDUFS8,"Among the genes DOLPP1, CYB561D2, NDUFS8, PGM1, and TRAF3IP1, which one exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Among the genes DOLPP1, CYB561D2, NDUFS8, PGM1, and TRAF3IP1, which one exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the regulatory T cell–activated genes in PINNACLE. For the overlapping genes, compute an average embedding as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PCDHA12', 'UQCRB', 'SF1', 'NDUFB11', 'PLEKHM2']",follicular lymphoma,regulatory t cell,NDUFB11,"Among the genes PCDHA12, UQCRB, SF1, NDUFB11, and PLEKHM2, which exhibits the highest regulatory T cell-specific expression relevant to targeting follicular lymphoma?","Among the genes PCDHA12, UQCRB, SF1, NDUFB11, and PLEKHM2, which exhibits the highest regulatory T cell-specific expression relevant to targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which regulatory T cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA7', 'DDIT4L', 'GOLGA6L9', 'AIFM1', 'CBLC']",follicular lymphoma,regulatory t cell,NDUFA7,"Among NDUFA7, DDIT4L, GOLGA6L9, AIFM1, and CBLC, which gene shows the highest specificity for regulatory T cells in the context of targeting follicular lymphoma?","Among NDUFA7, DDIT4L, GOLGA6L9, AIFM1, and CBLC, which gene shows the highest specificity for regulatory T cells in the context of targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which regulatory T cell-activated genes overlap with these targets to form a cell-type–specific target set. Compute the average embedding of this set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a substantially higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SMARCD3', 'ATP6V0E2', 'TRIM52', 'MCL1', 'AFDN']",follicular lymphoma,regulatory t cell,MCL1,"Among SMARCD3, ATP6V0E2, TRIM52, MCL1, and AFDN, which gene displays the highest cell-type specificity in regulatory T cells as a potential target for follicular lymphoma?","Among SMARCD3, ATP6V0E2, TRIM52, MCL1, and AFDN, which gene displays the highest cell-type specificity in regulatory T cells as a potential target for follicular lymphoma? Using the PINNACLE database, first identify all verified therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings. Next, isolate the genes that are shared with the regulatory T cell–activated gene set in PINNACLE. Calculate the average embedding of these overlapping genes and then compute the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['MRPL9', 'TRMT112', 'CLSPN', 'STRIP1', 'CD3G']",follicular lymphoma,regulatory t cell,CD3G,"Which gene—MRPL9, TRMT112, CLSPN, STRIP1, or CD3G—exhibits the greatest regulatory T cell-specific expression, making it the most promising target for follicular lymphoma therapy?","Which gene—MRPL9, TRMT112, CLSPN, STRIP1, or CD3G—exhibits the greatest regulatory T cell-specific expression, making it the most promising target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which PINNACLE regulatory T cell-activated genes overlap with these targets to define cell-type–specific candidates. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA6', 'OGT', 'GPS1', 'CSNK1A1L', 'GAS2L3']",follicular lymphoma,regulatory t cell,NDUFA6,"Which gene—NDUFA6, OGT, GPS1, CSNK1A1L, or GAS2L3—displays the highest specificity for regulatory T cells in relation to follicular lymphoma targeting?","Which gene—NDUFA6, OGT, GPS1, CSNK1A1L, or GAS2L3—displays the highest specificity for regulatory T cells in relation to follicular lymphoma targeting? Identify validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in regulatory T cells within PINNACLE. For these overlapping genes, compute an average embedding to serve as a reference, then calculate the cosine similarity between this reference and the embedding of each individual gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ADAM21', 'NDUFS4', 'PLEKHG4', 'HIBADH', 'CARTPT']",follicular lymphoma,regulatory t cell,NDUFS4,"Among the genes ADAM21, NDUFS4, PLEKHG4, HIBADH, and CARTPT, which one exhibits the highest cell-type specificity in regulatory T cells as a candidate for targeted follicular lymphoma therapy?","Among the genes ADAM21, NDUFS4, PLEKHG4, HIBADH, and CARTPT, which one exhibits the highest cell-type specificity in regulatory T cells as a candidate for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the regulatory T cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference vector, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RBX1', 'TMEM74B', 'VPS37C', 'GDNF', 'HMGCS2']",follicular lymphoma,regulatory t cell,RBX1,"Which of the following genes—RBX1, TMEM74B, VPS37C, GDNF, or HMGCS2—exhibits the highest cell-type specificity in regulatory T cells, making it the most promising candidate for targeting follicular lymphoma?","Which of the following genes—RBX1, TMEM74B, VPS37C, GDNF, or HMGCS2—exhibits the highest cell-type specificity in regulatory T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which regulatory T-cell activated genes in PINNACLE overlap with these targets, thereby defining a cell-type–specific target set for follicular lymphoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between the average and each individual target embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PCYOX1', 'PSMA2', 'R3HCC1', 'JAK1', 'PRODH2']",follicular lymphoma,regulatory t cell,JAK1,"Among the genes PCYOX1, PSMA2, R3HCC1, JAK1, and PRODH2, which one exhibits the highest cell-type specificity in regulatory T cells for follicular lymphoma targeting?","Among the genes PCYOX1, PSMA2, R3HCC1, JAK1, and PRODH2, which one exhibits the highest cell-type specificity in regulatory T cells for follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type specific embeddings from PINNACLE. Next, determine which of these targets overlap with the regulatory T cell–activated genes in PINNACLE, thereby defining a set of cell-specific targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this mean embedding and that of each individual target. Finally, if one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STMN3', 'GNB5', 'FBXO32', 'HDAC2', 'ZBTB43']",follicular lymphoma,regulatory t cell,HDAC2,"Which gene—STMN3', GNB5, FBXO32, HDAC2, or ZBTB43—displays the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Which gene—STMN3', GNB5, FBXO32, HDAC2, or ZBTB43—displays the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets to establish a set of cell-type–specific candidates. Calculate the average embedding of this set as a reference, then assess the cosine similarity between each individual target’s embedding and the reference. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance in follicular lymphoma."
"['F2R', 'TNFRSF4', 'POLM', 'LRGUK', 'TM9SF3']",follicular lymphoma,regulatory t cell,TNFRSF4,"Which gene among F2R, TNFRSF4, POLM, LRGUK, and TM9SF3 displays the highest specificity for regulatory T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among F2R, TNFRSF4, POLM, LRGUK, and TM9SF3 displays the highest specificity for regulatory T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type specific embeddings from PINNACLE. Next, determine which genes activated in regulatory T cells from PINNACLE overlap with these targets to define the relevant cell-type specific targets. Calculate the mean embedding of this overlapping set and compute the cosine similarity between this reference embedding and each individual target. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['SLC34A2', 'EMC2', 'SLC17A9', 'NDUFA11', 'EIF4EBP2']",follicular lymphoma,regulatory t cell,NDUFA11,"Which gene among SLC34A2, EMC2, SLC17A9, NDUFA11, and EIF4EBP2 displays the most specific expression in regulatory T cells, thereby representing the best candidate for targeting follicular lymphoma?","Which gene among SLC34A2, EMC2, SLC17A9, NDUFA11, and EIF4EBP2 displays the most specific expression in regulatory T cells, thereby representing the best candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, pinpoint the genes activated in regulatory T cells that overlap with these targets. For this overlapping set, compute the average embedding as a reference and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IL32', 'NDUFB2', 'INSL3', 'TRAK2', 'NAPB']",follicular lymphoma,regulatory t cell,NDUFB2,"Which gene among IL32, NDUFB2, INSL3, TRAK2, and NAPB exhibits the highest cell-type specificity in regulatory T cells for targeted treatment of follicular lymphoma?","Which gene among IL32, NDUFB2, INSL3, TRAK2, and NAPB exhibits the highest cell-type specificity in regulatory T cells for targeted treatment of follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific gene embeddings from the PINNACLE database. Next, determine the overlap between these targets and regulatory T cell–activated genes in PINNACLE, designating this common set as cell-type–specific targets. Compute the average embedding of these genes and then calculate the cosine similarity between this average and each target’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UPF1', 'CHRAC1', 'NDUFB5', 'VSIG1', 'NUDCD2']",follicular lymphoma,regulatory t cell,NDUFB5,"Among the genes UPF1, CHRAC1, NDUFB5, VSIG1, and NUDCD2, which one exhibits the highest specificity in regulatory T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes UPF1, CHRAC1, NDUFB5, VSIG1, and NUDCD2, which one exhibits the highest specificity in regulatory T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['NECTIN2', 'NDUFS3', 'DDAH1', 'ORAI2', 'SHISA3']",follicular lymphoma,exhausted t cell,NDUFS3,"Among NECTIN2, NDUFS3, DDAH1, ORAI2, and SHISA3, which gene demonstrates the highest cell-type specificity in exhausted T cells and represents the most promising target for follicular lymphoma?","Among NECTIN2, NDUFS3, DDAH1, ORAI2, and SHISA3, which gene demonstrates the highest cell-type specificity in exhausted T cells and represents the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type specific embeddings from PINNACLE. Next, cross-reference these targets with PINNACLE’s exhausted T cell-activated gene set to obtain the overlapping subset of cell-type-specific targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CRYZL1', 'RAPGEF6', 'NDUFA8', 'MX2', 'LTF']",follicular lymphoma,exhausted t cell,NDUFA8,"Among the genes CRYZL1, RAPGEF6, NDUFA8, MX2, and LTF, which one exhibits the highest specificity in exhausted T cells as a target for follicular lymphoma therapy?","Among the genes CRYZL1, RAPGEF6, NDUFA8, MX2, and LTF, which one exhibits the highest specificity in exhausted T cells as a target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which exhausted T cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding of the overlapping gene set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological importance."
"['GAB3', 'CCDC113', 'DMXL1', 'NDUFS2', 'RIPK2']",follicular lymphoma,exhausted t cell,NDUFS2,"Among the genes GAB3, CCDC113, DMXL1, NDUFS2, and RIPK2, which one demonstrates the highest cell-type specificity in exhausted T cells as a potential therapeutic target for follicular lymphoma?","Among the genes GAB3, CCDC113, DMXL1, NDUFS2, and RIPK2, which one demonstrates the highest cell-type specificity in exhausted T cells as a potential therapeutic target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which exhausted T cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target gene's embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TM2D2', 'TRA2A', 'HDAC8', 'LGALS2', 'SMCP']",follicular lymphoma,exhausted t cell,HDAC8,"Among TM2D2, TRA2A, HDAC8, LGALS2, and SMCP, which gene shows the highest expression specificity in exhausted T cells in follicular lymphoma, thereby representing the single best candidate for targeted therapy?","Among TM2D2, TRA2A, HDAC8, LGALS2, and SMCP, which gene shows the highest expression specificity in exhausted T cells in follicular lymphoma, thereby representing the single best candidate for targeted therapy? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of exhausted T cell–activated genes in PINNACLE. For the overlapping genes, compute their average embedding and calculate the cosine similarity between this average and the embedding of each target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFNAR2', 'RRP12', 'PIGU', 'AGXT', 'HMOX2']",follicular lymphoma,exhausted t cell,IFNAR2,"Among the genes IFNAR2, RRP12, PIGU, AGXT, and HMOX2, which one demonstrates the greatest cell-type specificity in exhausted T cells for the targeted treatment of follicular lymphoma?","Among the genes IFNAR2, RRP12, PIGU, AGXT, and HMOX2, which one demonstrates the greatest cell-type specificity in exhausted T cells for the targeted treatment of follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which exhausted T cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for this lymphoma. Compute the average embedding for this gene set and calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene demonstrates markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MC1R', 'LCT', 'CALM2', 'TMEM254', 'NDUFA6']",follicular lymphoma,exhausted t cell,NDUFA6,"Among the genes MC1R, LCT, CALM2, TMEM254, and NDUFA6, which one demonstrates the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma?","Among the genes MC1R, LCT, CALM2, TMEM254, and NDUFA6, which one demonstrates the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, find the intersection between these targets and the genes associated with exhausted T-cell activation in PINNACLE to establish a set of cell-type–specific targets. Calculate the average embedding for this overlapping set to serve as a reference, and then compute the cosine similarity between this reference and the embedding of each individual gene. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['RIN1', 'DUT', 'NDUFA3', 'ERICH4', 'SERPINB12']",follicular lymphoma,exhausted t cell,NDUFA3,"Among the genes RIN1, DUT, NDUFA3, ERICH4, and SERPINB12, which one exhibits the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma?","Among the genes RIN1, DUT, NDUFA3, ERICH4, and SERPINB12, which one exhibits the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the intersection between these targets and the genes associated with exhausted T cell activation in PINNACLE. Compute the average embedding for the overlapping genes as a reference, and then calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows substantially higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['NPLOC4', 'ATRN', 'TAOK3', 'NDUFS6', 'LOXHD1']",follicular lymphoma,exhausted t cell,NDUFS6,"Which gene, among NPLOC4, ATRN, TAOK3, NDUFS6, and LOXHD1, displays the highest specificity for exhausted T cells, making it the most promising target for follicular lymphoma therapy?","Which gene, among NPLOC4, ATRN, TAOK3, NDUFS6, and LOXHD1, displays the highest specificity for exhausted T cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which exhausted T cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set. Compute the average embedding of this set to serve as a reference, and then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HHAT', 'FOXJ2', 'PDCD1', 'PLP1', 'KIAA2026']",follicular lymphoma,exhausted t cell,PDCD1,"Among the genes HHAT, FOXJ2, PDCD1, PLP1, and KIAA2026, which one displays the highest cell-type specificity in exhausted T cells, suggesting it as the most promising target for follicular lymphoma?","Among the genes HHAT, FOXJ2, PDCD1, PLP1, and KIAA2026, which one displays the highest cell-type specificity in exhausted T cells, suggesting it as the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the exhausted T cell–activated genes available in PINNACLE to define the cell-type–specific targets. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MINK1', 'TIMP2', 'MAP4K2', 'NDUFB1', 'LVRN']",follicular lymphoma,exhausted t cell,NDUFB1,"Among MINK1, TIMP2, MAP4K2, NDUFB1, and LVRN, which gene exhibits the highest cell-type specificity in exhausted T cells for potential targeting of follicular lymphoma?","Among MINK1, TIMP2, MAP4K2, NDUFB1, and LVRN, which gene exhibits the highest cell-type specificity in exhausted T cells for potential targeting of follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, compare these targets with the exhausted T cell-activated genes in PINNACLE to obtain the overlapping set as cell-type-specific targets for follicular lymphoma. Calculate the average embedding of this overlap and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFAF3', 'GCG', 'CEP57', 'NRM', 'IL13']",follicular lymphoma,exhausted t cell,NDUFAF3,"Which gene among NDUFAF3, GCG, CEP57, NRM, and IL13 exhibits the highest cell-type specificity in exhausted T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among NDUFAF3, GCG, CEP57, NRM, and IL13 exhibits the highest cell-type specificity in exhausted T cells, making it the optimal candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of exhausted T cell–activated genes from PINNACLE, thereby pinpointing candidate cell-type–specific targets for follicular lymphoma. Calculate the average embedding of these candidate genes and then compute the cosine similarity between this average embedding and each individual candidate embedding. If one gene demonstrates a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CRBN', 'U2AF1', 'KCNK7', 'PCYT1A', 'DECR1']",follicular lymphoma,exhausted t cell,CRBN,"Which gene among CRBN, U2AF1, KCNK7, PCYT1A, and DECR1 exhibits the highest cell-type specificity in exhausted T cells to serve as the optimal target for follicular lymphoma?","Which gene among CRBN, U2AF1, KCNK7, PCYT1A, and DECR1 exhibits the highest cell-type specificity in exhausted T cells to serve as the optimal target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes associated with exhausted T cell activation overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for these overlapping genes as a reference profile, and then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits distinctly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['KLK6', 'MT-ND4L', 'SPATA25', 'EPPK1', 'PYGB']",follicular lymphoma,exhausted t cell,MT-ND4L,"Among the genes KLK6, MT-ND4L, SPATA25, EPPK1, and PYGB, which one exhibits the highest specificity for exhausted T cells in the context of follicular lymphoma?","Among the genes KLK6, MT-ND4L, SPATA25, EPPK1, and PYGB, which one exhibits the highest specificity for exhausted T cells in the context of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which exhausted T cell activation genes in PINNACLE overlap with these targets, and compute the average embedding of the overlapping set. Finally, calculate the cosine similarity between this average embedding and the individual gene embeddings. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide an evidence-based rationale supporting its biological relevance."
"['TUBB', 'CD320', 'FUT11', 'SLC46A3', 'CD163']",follicular lymphoma,exhausted t cell,TUBB,"Which gene among TUBB, CD320, FUT11, SLC46A3, and CD163 exhibits the highest specificity in exhausted T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among TUBB, CD320, FUT11, SLC46A3, and CD163 exhibits the highest specificity in exhausted T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the exhausted T cell–activated genes cataloged in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set to serve as a reference, and compute the cosine similarity between this reference and each individual target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['PURA', 'NDUFA10', 'DCAF12', 'ACAA1', 'BET1L']",follicular lymphoma,exhausted t cell,NDUFA10,"Among the genes PURA, NDUFA10, DCAF12, ACAA1, and BET1L, which one exhibits the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma?","Among the genes PURA, NDUFA10, DCAF12, ACAA1, and BET1L, which one exhibits the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma using PINNACLE and obtain their cell-type–specific embeddings. Next, from the set of exhausted T cell–activated genes in PINNACLE, determine which genes overlap with these targets to form a refined list of cell-type–specific targets. Calculate the average embedding of this list and then compute the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ORMDL3', 'LAG3', 'SLC25A4', 'GNB2', 'SCO2']",follicular lymphoma,exhausted t cell,LAG3,"Which gene—ORMDL3, LAG3, SLC25A4, GNB2, or SCO2—demonstrates the highest specificity to exhausted T cells, making it the most promising single candidate for targeting follicular lymphoma?","Which gene—ORMDL3, LAG3, SLC25A4, GNB2, or SCO2—demonstrates the highest specificity to exhausted T cells, making it the most promising single candidate for targeting follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the intersection between these targets and the set of exhausted T cell-activated genes in PINNACLE, thus defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and determine the cosine similarity between this reference embedding and each individual target within the set. If one gene exhibits a distinctly higher cosine similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CKMT1A', 'LRSAM1', 'DRG1', 'RBX1', 'SLC23A2']",follicular lymphoma,exhausted t cell,RBX1,"Which gene among CKMT1A, LRSAM1, DRG1, RBX1, and SLC23A2 demonstrates the highest specificity in exhausted T cells within follicular lymphoma?","Which gene among CKMT1A, LRSAM1, DRG1, RBX1, and SLC23A2 demonstrates the highest specificity in exhausted T cells within follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, determine the intersection between these targets and the exhausted T cell-activated genes in PINNACLE to define the cell-type-specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['YES1', 'BCAS2', 'ADCY9', 'OR2G6', 'VGF']",follicular lymphoma,exhausted t cell,YES1,"Among the genes YES1, BCAS2, ADCY9, OR2G6, and VGF, which exhibits the highest cell-type specificity in exhausted T cells, thereby making it the most promising candidate for targeting follicular lymphoma?","Among the genes YES1, BCAS2, ADCY9, OR2G6, and VGF, which exhibits the highest cell-type specificity in exhausted T cells, thereby making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets intersect with the exhausted T cell activation-related genes in PINNACLE to obtain a set of candidate cell-type–specific targets. Calculate the average embedding of this set and compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DNASE1', 'NDUFA12', 'MAGEE2', 'PPM1D', 'ST3GAL5']",follicular lymphoma,exhausted t cell,NDUFA12,"Among the genes DNASE1, NDUFA12, MAGEE2, PPM1D, and ST3GAL5, which one exhibits the greatest cell-type specificity in exhausted T cells, making it the most promising target for follicular lymphoma therapy?","Among the genes DNASE1, NDUFA12, MAGEE2, PPM1D, and ST3GAL5, which one exhibits the greatest cell-type specificity in exhausted T cells, making it the most promising target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the exhausted T cell–activated genes in PINNACLE to define the disease-relevant subset. Calculate the average embedding for this subset and then compute the cosine similarity between this average reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based explanation for its biological relevance."
"['ZNF236', 'ZRSR2P1', 'NDUFC2', 'SLC13A3', 'SLC14A1']",follicular lymphoma,exhausted t cell,NDUFC2,"Among the genes ZNF236, ZRSR2P1, NDUFC2, SLC13A3, and SLC14A1, which one exhibits the highest cell-type specificity in exhausted T cells for targeted therapy in follicular lymphoma?","Among the genes ZNF236, ZRSR2P1, NDUFC2, SLC13A3, and SLC14A1, which one exhibits the highest cell-type specificity in exhausted T cells for targeted therapy in follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the exhausted T cell-activated genes in PINNACLE to define cell-type–specific targets for follicular lymphoma. For this overlapping set, compute the average embedding and calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CCBE1', 'APBA2', 'SFN', 'SCD5', 'NDUFS5']",follicular lymphoma,t cell,NDUFS5,"Which gene among CCBE1, APBA2, SFN, SCD5, and NDUFS5 exhibits the highest T cell-specific expression for targeted interventions in follicular lymphoma?","Which gene among CCBE1, APBA2, SFN, SCD5, and NDUFS5 exhibits the highest T cell-specific expression for targeted interventions in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which T cell–activated genes in PINNACLE overlap with these targets to define the relevant cell-type–specific targets. Calculate the average embedding for these overlapping genes and assess the cosine similarity between this average and each individual gene’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CPNE3', 'IL6R', 'S100A11', 'H2BC4', 'ENO1']",follicular lymphoma,t cell,IL6R,"Which gene among CPNE3, IL6R, S100A11, H2BC4, and ENO1 demonstrates the highest T cell-specific expression relevant for targeting follicular lymphoma?","Which gene among CPNE3, IL6R, S100A11, H2BC4, and ENO1 demonstrates the highest T cell-specific expression relevant for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the set of T cell-activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of this overlap to serve as a reference, then calculate the cosine similarity between this reference and each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AP1G1', 'ELSPBP1', 'NDUFS8', 'POLR2J3', 'SMIM19']",follicular lymphoma,t cell,NDUFS8,"Among the genes AP1G1, ELSPBP1, NDUFS8, POLR2J3, and SMIM19, which exhibits the most T cell–specific expression for targeting follicular lymphoma?","Among the genes AP1G1, ELSPBP1, NDUFS8, POLR2J3, and SMIM19, which exhibits the most T cell–specific expression for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of T cell–activated genes in PINNACLE. For the overlapping genes, calculate the average embedding and then compute the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PHAX', 'GSR', 'CCN1', 'TMEM139', 'KCTD6']",follicular lymphoma,t cell,GSR,"Which gene among PHAX, GSR, CCN1, TMEM139, and KCTD6 exhibits the highest specificity for T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among PHAX, GSR, CCN1, TMEM139, and KCTD6 exhibits the highest specificity for T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, identify which T cell–activated genes in PINNACLE intersect with these targets to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological significance."
"['SLC25A10', 'CDK9', 'STEAP1B', 'TRA', 'HEBP2']",follicular lymphoma,t cell,CDK9,"Which gene among SLC25A10, CDK9, STEAP1B, TRA, and HEBP2 demonstrates the highest T-cell specificity for targeting follicular lymphoma?","Which gene among SLC25A10, CDK9, STEAP1B, TRA, and HEBP2 demonstrates the highest T-cell specificity for targeting follicular lymphoma? Identify the validated therapeutic target genes for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which T cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FNIP1', 'TOP2A', 'MDFIC', 'TRIM62', 'PRCP']",follicular lymphoma,t cell,TOP2A,"Which gene among FNIP1, TOP2A, MDFIC, TRIM62, and PRCP exhibits the highest T cell-specific expression, making it the optimal candidate for targeted intervention in follicular lymphoma?","Which gene among FNIP1, TOP2A, MDFIC, TRIM62, and PRCP exhibits the highest T cell-specific expression, making it the optimal candidate for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with t cell–activated genes in PINNACLE. Next, compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HAPLN2', 'ZMPSTE24', 'ZNF44', 'NDUFAF3', 'CD74']",follicular lymphoma,t cell,NDUFAF3,"Among HAPLN2, ZMPSTE24, ZNF44, NDUFAF3, and CD74, which gene exhibits the highest T cell–specific expression relevant to targeting follicular lymphoma?","Among HAPLN2, ZMPSTE24, ZNF44, NDUFAF3, and CD74, which gene exhibits the highest T cell–specific expression relevant to targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between the average and each individual target’s embedding. If a single gene shows a significantly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFAF1', 'FUZ', 'KIF16B', 'COG3', 'CD80']",follicular lymphoma,t cell,NDUFAF1,"Among the genes NDUFAF1, FUZ, KIF16B, COG3, and CD80, which one demonstrates the highest T cell-specific expression relevant to follicular lymphoma targeting?","Among the genes NDUFAF1, FUZ, KIF16B, COG3, and CD80, which one demonstrates the highest T cell-specific expression relevant to follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which T cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding as a reference vector and calculate the cosine similarity between this reference and each target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CTBP1', 'CYREN', 'SLC1A5', 'DAAM1', 'NDUFV1']",follicular lymphoma,t cell,NDUFV1,"Which gene among CTBP1, CYREN, SLC1A5, DAAM1, and NDUFV1 exhibits the highest T cell-specific expression relevant to targeting follicular lymphoma?","Which gene among CTBP1, CYREN, SLC1A5, DAAM1, and NDUFV1 exhibits the highest T cell-specific expression relevant to targeting follicular lymphoma? Using PINNACLE, identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings. Next, determine which of these targets overlap with T cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CRABP2', 'SUSD6', 'MT-CO3', 'HSP90AA1', 'EMX1']",follicular lymphoma,t cell,HSP90AA1,"Among the genes CRABP2, SUSD6, MT-CO3, HSP90AA1, and EMX1, which one exhibits the highest specificity for T cells and represents the best candidate for targeting follicular lymphoma?","Among the genes CRABP2, SUSD6, MT-CO3, HSP90AA1, and EMX1, which one exhibits the highest specificity for T cells and represents the best candidate for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with t cell–activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding for this overlapping set, and calculate the cosine similarity of each individual target's embedding to this average. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CD79B', 'MTARC1', 'HIC2', 'SPOCK1', 'TPRX1']",follicular lymphoma,t cell,CD79B,"Among the genes CD79B, MTARC1, HIC2, SPOCK1, and TPRX1, which one exhibits the most T-cell–specific expression that could be leveraged for targeted follicular lymphoma therapies?","Among the genes CD79B, MTARC1, HIC2, SPOCK1, and TPRX1, which one exhibits the most T-cell–specific expression that could be leveraged for targeted follicular lymphoma therapies? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the T cell–activated genes in PINNACLE to form a set of cell-type–specific targets. Compute the average embedding of this set and then calculate the cosine similarity between this average and each individual target. If one gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SOWAHC', 'MYH7', 'TOP1', 'FNBP1', 'CDC25A']",follicular lymphoma,t cell,TOP1,"Among the genes SOWAHC, MYH7, TOP1, FNBP1, and CDC25A, which exhibits the greatest T-cell specificity for targeting follicular lymphoma?","Among the genes SOWAHC, MYH7, TOP1, FNBP1, and CDC25A, which exhibits the greatest T-cell specificity for targeting follicular lymphoma? Using PINNACLE data, identify validated therapeutic targets for follicular lymphoma and retrieve their cell‐type‐specific embeddings. Next, determine which of these targets overlap with genes associated with T cell activation in PINNACLE. Calculate the average embedding of the overlapping targets and compute the cosine similarity between this average and each individual target embedding. Finally, nominate the gene with the highest similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DDX1', 'TRAPPC2B', 'ENG', 'MCL1', 'ARID1B']",follicular lymphoma,t cell,MCL1,"Among the genes DDX1, TRAPPC2B, ENG, MCL1, and ARID1B, which one exhibits the highest specificity in T cells, making it the most promising target for follicular lymphoma therapy?","Among the genes DDX1, TRAPPC2B, ENG, MCL1, and ARID1B, which one exhibits the highest specificity in T cells, making it the most promising target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma in the PINNACLE dataset and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with the t cell–activated gene set in PINNACLE. For the overlapping genes, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CHORDC1', 'FBXW7', 'DHFR', 'FOXA2', 'SPHK2']",follicular lymphoma,t cell,DHFR,"Among the genes CHORDC1, FBXW7, DHFR, FOXA2, and SPHK2, which one demonstrates the highest T cell-specific expression for potential targeting of follicular lymphoma?","Among the genes CHORDC1, FBXW7, DHFR, FOXA2, and SPHK2, which one demonstrates the highest T cell-specific expression for potential targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which t cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SV2B', 'PPP1R2C', 'CTTNBP2NL', 'PSD', 'BCR']",follicular lymphoma,t cell,BCR,"Among the genes SV2B, PPP1R2C, CTTNBP2NL, PSD, and BCR, which exhibits the most T cell–specific expression for potential targeting of follicular lymphoma?","Among the genes SV2B, PPP1R2C, CTTNBP2NL, PSD, and BCR, which exhibits the most T cell–specific expression for potential targeting of follicular lymphoma? Using the PINNACLE dataset, identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with the T cell–activated gene set in PINNACLE. Compute the average embedding for this overlapping group and calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise and evidence-based rationale for its biological relevance."
"['NDUFB8', 'PHC1', 'PHF14', 'CKMT1A', 'UBE2N']",follicular lymphoma,t cell,NDUFB8,"Among the genes NDUFB8, PHC1, PHF14, CKMT1A, and UBE2N, which one exhibits the most T cell-specific expression and is therefore the most promising candidate for targeted intervention in follicular lymphoma?","Among the genes NDUFB8, PHC1, PHF14, CKMT1A, and UBE2N, which one exhibits the most T cell-specific expression and is therefore the most promising candidate for targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, delineate the overlap between these targets and the t cell–activated gene set in PINNACLE to establish a subset of cell-type–specific targets for follicular lymphoma. Calculate the average embedding for these overlapping genes and then compute the cosine similarity between this reference vector and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARHGAP21', 'NDUFA9', 'ELANE', 'UBE4A', 'ZFP64']",follicular lymphoma,t cell,NDUFA9,"Among ARHGAP21, NDUFA9, ELANE, UBE4A, and ZFP64, which gene exhibits the highest T cell–specific expression for targeted therapy in follicular lymphoma?","Among ARHGAP21, NDUFA9, ELANE, UBE4A, and ZFP64, which gene exhibits the highest T cell–specific expression for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which targets overlap with genes activated in T cells from PINNACLE, defining this common subset as the follicular lymphoma-specific targets. Compute the average embedding for this subset, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SHOX', 'CAMK1G', 'MEF2C', 'PIK3CG', 'NDRG4']",follicular lymphoma,t cell,PIK3CG,"Among the genes SHOX, CAMK1G, MEF2C, PIK3CG, and NDRG4, which shows the highest T cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes SHOX, CAMK1G, MEF2C, PIK3CG, and NDRG4, which shows the highest T cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify which T cell–activated genes in PINNACLE overlap with these targets to define a specific subset for follicular lymphoma. Compute the average embedding for this subset as a reference vector, then calculate the cosine similarity between this reference and each individual candidate. If one gene exhibits a notably higher similarity compared to the others, nominate this gene as the top candidate and provide a concise, evidence-based explanation for its potential biological relevance."
"['TAF13', 'KCNJ18', 'RAB33A', 'NDUFS3', 'TPD52L3']",follicular lymphoma,t cell,NDUFS3,"Which candidate gene—TAF13, KCNJ18, RAB33A, NDUFS3, or TPD52L3—exhibits the highest specificity of expression in T cells within the context of follicular lymphoma?","Which candidate gene—TAF13, KCNJ18, RAB33A, NDUFS3, or TPD52L3—exhibits the highest specificity of expression in T cells within the context of follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, assess the overlap between these targets and the t cell-activated genes in PINNACLE to define the cell-specific targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PPP2R3B', 'CELF2', 'EZH1', 'PDCD2L', 'CTNNAL1']",follicular lymphoma,t cell,CELF2,"Among the genes PPP2R3B, CELF2, EZH1, PDCD2L, and CTNNAL1, which one exhibits the highest T-cell specificity for targeting follicular lymphoma?","Among the genes PPP2R3B, CELF2, EZH1, PDCD2L, and CTNNAL1, which one exhibits the highest T-cell specificity for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TM4SF1', 'IKBKB', 'SALL4', 'NDUFB3', 'AFF1']",follicular lymphoma,mature nk t cell,NDUFB3,"Among the genes TM4SF1, IKBKB, SALL4, NDUFB3, and AFF1, which one exhibits the highest cell-type specificity in mature NK T cells for targeted therapy against follicular lymphoma?","Among the genes TM4SF1, IKBKB, SALL4, NDUFB3, and AFF1, which one exhibits the highest cell-type specificity in mature NK T cells for targeted therapy against follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, identify the overlap between these targets and the mature NK T cell-activated genes within the PINNACLE dataset to define a set of cell-type–specific targets. Calculate the average embedding for this set and compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TOMM40', 'FYN', 'ATP2B1', 'TRIM15', 'ARRB1']",follicular lymphoma,mature nk t cell,FYN,"Which gene among TOMM40, FYN, ATP2B1, TRIM15, and ARRB1 exhibits the highest cell-type specificity in mature NK/T cells for targeting follicular lymphoma?","Which gene among TOMM40, FYN, ATP2B1, TRIM15, and ARRB1 exhibits the highest cell-type specificity in mature NK/T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which mature NK T cell-activated genes in PINNACLE overlap with these targets to establish a subset of candidate cell-type–specific targets. Compute the average embedding for this subset and calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KIF24', 'SH3BP1', 'TUBB', 'MRPL51', 'RAD23A']",follicular lymphoma,mature nk t cell,TUBB,"Among the genes KIF24, SH3BP1, TUBB, MRPL51, and RAD23A, which one exhibits the highest cell-type specificity in mature NK T-cells for follicular lymphoma targeting?","Among the genes KIF24, SH3BP1, TUBB, MRPL51, and RAD23A, which one exhibits the highest cell-type specificity in mature NK T-cells for follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap with mature activated NK T cell genes in PINNACLE to define a cell-type–specific target set. Calculate the average embedding for this set as a reference and then compute the cosine similarity between the reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['DLGAP5', 'CD38', 'DCTN3', 'OSBPL10', 'SEC61G']",follicular lymphoma,mature nk t cell,CD38,"Which gene among DLGAP5, CD38, DCTN3, OSBPL10, and SEC61G exhibits the highest cell-type specific expression in mature NK T cells, making it the most promising target for follicular lymphoma treatment?","Which gene among DLGAP5, CD38, DCTN3, OSBPL10, and SEC61G exhibits the highest cell-type specific expression in mature NK T cells, making it the most promising target for follicular lymphoma treatment? Identify and retrieve the cell-type–specific embeddings from PINNACLE for all verified therapeutic targets of follicular lymphoma. Next, determine the intersection of these targets with the mature NK T cell-activated genes in PINNACLE to define the cell-type–specific targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and the embedding of each individual gene. Finally, if one gene exhibits a significantly higher cosine similarity compared to the others, nominate it as the leading candidate and provide a concise, evidence-based explanation of its biological relevance in follicular lymphoma."
"['DGCR2', 'FOLR2', 'PIK3CD', 'VAPB', 'USP17L7']",follicular lymphoma,mature nk t cell,PIK3CD,"Which gene among DGCR2, FOLR2, PIK3CD, VAPB, and USP17L7 exhibits the highest cell-type-specific expression in mature NKT cells and represents the best candidate for targeting follicular lymphoma?","Which gene among DGCR2, FOLR2, PIK3CD, VAPB, and USP17L7 exhibits the highest cell-type-specific expression in mature NKT cells and represents the best candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which genes from the mature NK T cell-activated gene set in PINNACLE overlap with these targets to define the cell-type-specific targets for follicular lymphoma. Calculate the average embedding of the overlapping set and compute the cosine similarity between this average and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['AKNAD1', 'RBX1', 'SNX1', 'OPN1SW', 'CGB8']",follicular lymphoma,mature nk t cell,RBX1,"Which gene among AKNAD1, RBX1, SNX1, OPN1SW, and CGB8 demonstrates the most restricted expression in mature NK T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among AKNAD1, RBX1, SNX1, OPN1SW, and CGB8 demonstrates the most restricted expression in mature NK T cells, making it the optimal candidate for targeting follicular lymphoma? Which verified therapeutic targets for follicular lymphoma, with available cell-type–specific embeddings in PINNACLE, overlap with the set of mature NK T cell–activated genes? For the overlapping targets, calculate the average embedding to serve as a reference and determine the cosine similarity between this reference and each individual target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFITM2', 'ETFB', 'LAG3', 'MYCL', 'ZYG11B']",follicular lymphoma,mature nk t cell,LAG3,"Which gene—IFITM2, ETFB, LAG3, MYCL, or ZYG11B—exhibits the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma?","Which gene—IFITM2, ETFB, LAG3, MYCL, or ZYG11B—exhibits the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in mature NK T cells according to PINNACLE; this overlap defines the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this average and the embedding of each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['NAA25', 'XKR3', 'SETD4', 'DNMT3A', 'PDZK1IP1']",follicular lymphoma,mature nk t cell,DNMT3A,"Which gene—NAA25, XKR3, SETD4, DNMT3A, or PDZK1IP1—exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma?","Which gene—NAA25, XKR3, SETD4, DNMT3A, or PDZK1IP1—exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the mature NK T cell-activated genes recorded in PINNACLE. Compute the average embedding of the overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFB11', 'ATP2B2', 'PHLDA3', 'USPL1', 'KLK5']",follicular lymphoma,mature nk t cell,NDUFB11,"Which gene among NDUFB11, ATP2B2, PHLDA3, USPL1, and KLK5 exhibits the greatest cell‐type specificity in mature natural killer T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among NDUFB11, ATP2B2, PHLDA3, USPL1, and KLK5 exhibits the greatest cell‐type specificity in mature natural killer T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the mature NK T cell-activated genes in PINNACLE, defining this overlap as the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlap set, then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['RMND5B', 'HLA-DRB1', 'RPP25', 'LMO4', 'RAD52']",follicular lymphoma,mature nk t cell,HLA-DRB1,"Which gene among RMND5B, HLA-DRB1, RPP25, LMO4, and RAD52 exhibits the highest cell-type-specific expression in mature NK T cells for potential targeting of follicular lymphoma?","Which gene among RMND5B, HLA-DRB1, RPP25, LMO4, and RAD52 exhibits the highest cell-type-specific expression in mature NK T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic target genes for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of mature NK T cell-activated genes in PINNACLE. Using the overlapping set, compute an average embedding as a reference and calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a notably higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance in the context of follicular lymphoma."
"['PEX16', 'FSD2', 'CCDC158', 'NDUFS4', 'ANGPTL1']",follicular lymphoma,mature nk t cell,NDUFS4,"Among the following candidate genes—PEX16, FSD2, CCDC158, NDUFS4, and ANGPTL1—which one exhibits the highest cell-type specificity in mature natural killer T cells for targeted intervention in follicular lymphoma?","Among the following candidate genes—PEX16, FSD2, CCDC158, NDUFS4, and ANGPTL1—which one exhibits the highest cell-type specificity in mature natural killer T cells for targeted intervention in follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their corresponding cell-type-specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of mature NK T cell-activated genes available in PINNACLE to define the cell-type-specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this average embedding and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['NDUFB5', 'ARG2', 'MRPL43', 'RPL3L', 'EIF2B4']",follicular lymphoma,mature nk t cell,NDUFB5,"Among the genes NDUFB5, ARG2, MRPL43, RPL3L, and EIF2B4, which shows the most specific expression in mature NK T cells, making it the strongest candidate for follicular lymphoma targeting?","Among the genes NDUFB5, ARG2, MRPL43, RPL3L, and EIF2B4, which shows the most specific expression in mature NK T cells, making it the strongest candidate for follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the mature NK T cell–activated genes in PINNACLE to define the cell-type–specific targets. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CIB3', 'IL2RB', 'BCAS4', 'SAV1', 'NPIPB5']",follicular lymphoma,mature nk t cell,IL2RB,"Which gene among CIB3, IL2RB, BCAS4, SAV1, and NPIPB5 exhibits the highest cell-type specificity in mature NKT cells, thereby emerging as the most promising candidate for targeting follicular lymphoma?","Which gene among CIB3, IL2RB, BCAS4, SAV1, and NPIPB5 exhibits the highest cell-type specificity in mature NKT cells, thereby emerging as the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap with PINNACLE’s mature NK T cell-activated genes to define the cell-type–specific targets for this disease. Compute the average embedding of the overlapping set and then calculate the cosine similarity between this reference embedding and each individual target. If one gene consistently shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GPM6A', 'VDAC2', 'RNF20', 'BCL2A1', 'SLC9A1']",follicular lymphoma,mature nk t cell,BCL2A1,"Which gene among GPM6A, VDAC2, RNF20, BCL2A1, and SLC9A1 exhibits the highest specificity in mature NK T cells, making it the most promising candidate for follicular lymphoma targeting?","Which gene among GPM6A, VDAC2, RNF20, BCL2A1, and SLC9A1 exhibits the highest specificity in mature NK T cells, making it the most promising candidate for follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the overlapping set between these targets and the mature NK T cell–activated genes provided by PINNACLE, using this intersection as the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping targets and determine the cosine similarity between this reference embedding and each individual target’s embedding. Finally, identify the gene with a markedly higher similarity than the others, and provide a concise, evidence-based explanation for its biological relevance."
"['P4HA1', 'COQ6', 'CDK4', 'PDZK1IP1', 'FAM90A1']",follicular lymphoma,mature nk t cell,CDK4,"Which gene among P4HA1, COQ6, CDK4, PDZK1IP1, and FAM90A1 shows the most specific expression in mature natural killer T cells, making it the best candidate for targeted therapy in follicular lymphoma?","Which gene among P4HA1, COQ6, CDK4, PDZK1IP1, and FAM90A1 shows the most specific expression in mature natural killer T cells, making it the best candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE platform. Next, determine the subset of mature NK T cell-activated genes in PINNACLE that overlap with these targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIF', 'DEXI', 'DDB1', 'NEUROG3', 'RACK1']",follicular lymphoma,mature nk t cell,DDB1,"Which gene among PPIF, DEXI, DDB1, NEUROG3, and RACK1 exhibits the most cell-type-specific expression in mature natural killer T cells, making it the best candidate for targeting follicular lymphoma?","Which gene among PPIF, DEXI, DDB1, NEUROG3, and RACK1 exhibits the most cell-type-specific expression in mature natural killer T cells, making it the best candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma from PINNACLE and retrieve their cell-type–specific embeddings. Next, determine the subset of these targets that overlap with the mature NK T cell–activated genes in PINNACLE. Compute the average embedding for this overlapping set, and then calculate the cosine similarity between this average and the embedding of each gene within the set. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate for therapeutic targeting, and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFAB1', 'PLA2G5', 'TIAF1', 'LMOD3', 'SPRR3']",follicular lymphoma,mature nk t cell,NDUFAB1,"Among the genes NDUFAB1, PLA2G5, TIAF1, LMOD3, and SPRR3, which displays the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma?","Among the genes NDUFAB1, PLA2G5, TIAF1, LMOD3, and SPRR3, which displays the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, identify the overlap between these targets and the set of mature NK T cell–activated genes in PINNACLE, defining the overlapping genes as the cell-type–specific targets for follicular lymphoma. Compute the average embedding for the overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['KCNA10', 'ETNK1', 'SLC30A6', 'SERPINA5', 'NDUFS6']",follicular lymphoma,mature nk t cell,NDUFS6,"Among the genes KCNA10, ETNK1, SLC30A6, SERPINA5, and NDUFS6, which one exhibits the highest cell-type specificity in mature NK/T cells for targeting follicular lymphoma?","Among the genes KCNA10, ETNK1, SLC30A6, SERPINA5, and NDUFS6, which one exhibits the highest cell-type specificity in mature NK/T cells for targeting follicular lymphoma? Identify and extract the verified therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of mature NK T cell–activated genes in PINNACLE to define cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping gene set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TSEN54', 'HSP90AA1', 'RIPOR3', 'CDC27', 'NR1I2']",follicular lymphoma,mature nk t cell,HSP90AA1,"Among TSEN54, HSP90AA1, RIPOR3, CDC27, and NR1I2, which gene exhibits the highest cell-type specificity in mature NKT cells, making it the most promising candidate for targeting follicular lymphoma?","Among TSEN54, HSP90AA1, RIPOR3, CDC27, and NR1I2, which gene exhibits the highest cell-type specificity in mature NKT cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma in PINNACLE and retrieve their corresponding cell-type–specific embeddings. Next, from the set of mature NK T cell–activated genes in PINNACLE, determine which genes overlap with these targets. Compute the average embedding of this overlapping group and calculate the cosine similarity between this reference embedding and the embedding of each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PRPF31', 'POLE3', 'PLCXD3', 'UBE2H', 'ASAH1']",follicular lymphoma,mature nk t cell,POLE3,"Among the genes PRPF31, POLE3, PLCXD3, UBE2H, and ASAH1, which one demonstrates the highest cell-type specificity in mature NK T cells for potential targeting in follicular lymphoma?","Among the genes PRPF31, POLE3, PLCXD3, UBE2H, and ASAH1, which one demonstrates the highest cell-type specificity in mature NK T cells for potential targeting in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the mature NK T cell-activated genes in PINNACLE to define a set of cell-type–specific follicular lymphoma targets. Calculate the average embedding of these overlapping genes and then compute the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits a distinctly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZDHHC16', 'TOP2B', 'RBP3', 'SIKE1', 'ULBP1']",follicular lymphoma,myeloid cell,TOP2B,"Among the genes ZDHHC16, TOP2B, RBP3, SIKE1, and ULBP1, which one exhibits the highest specificity for myeloid cells as a potential target in follicular lymphoma?","Among the genes ZDHHC16, TOP2B, RBP3, SIKE1, and ULBP1, which one exhibits the highest specificity for myeloid cells as a potential target in follicular lymphoma? Identify the experimentally validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which myeloid cell-activated genes from PINNACLE overlap with these targets. Using the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each gene’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDC25C', 'NDUFB8', 'BCL3', 'CRLF2', 'SDHAF2']",follicular lymphoma,myeloid cell,NDUFB8,"Among the genes CDC25C, NDUFB8, BCL3, CRLF2, and SDHAF2, which one exhibits the highest myeloid cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes CDC25C, NDUFB8, BCL3, CRLF2, and SDHAF2, which one exhibits the highest myeloid cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma? Retrieve the verified therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings from PINNACLE. Identify the intersection between these targets and the myeloid cell-activated genes in PINNACLE, and calculate the average embedding for this overlapping set. Next, compute the cosine similarity between this average embedding and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['GALM', 'HLA-DRB1', 'MRPL13', 'LINC00518', 'PYROXD2']",follicular lymphoma,myeloid cell,HLA-DRB1,"Which gene—GALM, HLA-DRB1, MRPL13, LINC00518, or PYROXD2—exhibits the highest myeloid cell-type specificity for potential targeting in follicular lymphoma?","Which gene—GALM, HLA-DRB1, MRPL13, LINC00518, or PYROXD2—exhibits the highest myeloid cell-type specificity for potential targeting in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific PINNACLE embeddings. Next, determine which of these targets overlap with myeloid cell-activated genes in PINNACLE to define a cell-type–specific target set. Calculate the average embedding for this set and then compute the cosine similarity between this average and each individual target's embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IL12RB1', 'CD22', 'URB1-AS1', 'ANAPC11', 'PRM1']",follicular lymphoma,myeloid cell,CD22,"Among the genes IL12RB1, CD22, URB1-AS1, ANAPC11, and PRM1, which exhibits the greatest cell type-specific expression in myeloid cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes IL12RB1, CD22, URB1-AS1, ANAPC11, and PRM1, which exhibits the greatest cell type-specific expression in myeloid cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of myeloid cell-activated genes in PINNACLE. For the overlapping genes, compute an average embedding to serve as a reference, and then calculate the cosine similarity between this reference and each individual gene. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the primary candidate and provide a concise, evidence-supported rationale for its biological relevance."
"['ATP5PO', 'SH3BP4', 'CTPS2', 'KY', 'NDUFB3']",follicular lymphoma,myeloid cell,NDUFB3,"Among the genes ATP5PO, SH3BP4, CTPS2, KY, and NDUFB3, which one exhibits the highest myeloid cell specificity as a potential target in the context of follicular lymphoma?","Among the genes ATP5PO, SH3BP4, CTPS2, KY, and NDUFB3, which one exhibits the highest myeloid cell specificity as a potential target in the context of follicular lymphoma? For follicular lymphoma, identify validated therapeutic targets and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the myeloid cell–activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for the disease. Calculate the average embedding of these overlapping genes to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['SLC39A7', 'TAOK2', 'GDPD2', 'TUBB6', 'ANKIB1']",follicular lymphoma,myeloid cell,TUBB6,"Among genes SLC39A7, TAOK2, GDPD2, TUBB6, and ANKIB1, which exhibits the highest myeloid cell type specificity relevant to targeting follicular lymphoma?","Among genes SLC39A7, TAOK2, GDPD2, TUBB6, and ANKIB1, which exhibits the highest myeloid cell type specificity relevant to targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from the PINNACLE database. Next, determine which genes from the myeloid cell activation subset in PINNACLE overlap with these targets. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TPSAB1', 'MT-ND1', 'PRDX4', 'RBBP8', 'POP4']",follicular lymphoma,myeloid cell,MT-ND1,"Which gene among TPSAB1, MT-ND1, PRDX4, RBBP8, and POP4 exhibits the most specific expression in myeloid cells, making it the strongest candidate for targeted treatment in follicular lymphoma?","Which gene among TPSAB1, MT-ND1, PRDX4, RBBP8, and POP4 exhibits the most specific expression in myeloid cells, making it the strongest candidate for targeted treatment in follicular lymphoma? Identify all validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the myeloid cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set for follicular lymphoma. Compute the average embedding of this set and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IMPDH2', 'CNGB1', 'MPP7', 'ZFYVE1', 'POLR3K']",follicular lymphoma,myeloid cell,IMPDH2,"Among the genes IMPDH2, CNGB1, MPP7, ZFYVE1, and POLR3K, which demonstrates the highest cell-type specificity in myeloid cells for follicular lymphoma targeting?","Among the genes IMPDH2, CNGB1, MPP7, ZFYVE1, and POLR3K, which demonstrates the highest cell-type specificity in myeloid cells for follicular lymphoma targeting? Which verified therapeutic targets for follicular lymphoma can be identified within the PINNACLE cell‐type–specific embeddings? Identify the subset of these targets that overlap with myeloid cell–activated genes in PINNACLE, then compute the average embedding of this overlapping set. Next, calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPL8', 'MIA', 'FBXO21', 'NDUFB4', 'PPP1R1C']",follicular lymphoma,myeloid cell,NDUFB4,"Among the genes RPL8, MIA, FBXO21, NDUFB4, and PPP1R1C, which exhibits the highest specificity for myeloid cells and is most promising as a target for follicular lymphoma therapy?","Among the genes RPL8, MIA, FBXO21, NDUFB4, and PPP1R1C, which exhibits the highest specificity for myeloid cells and is most promising as a target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which myeloid cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific follicular lymphoma targets. Compute the average embedding for these overlapping genes as a reference vector, and then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['EN1', 'PSMB5', 'SHH', 'PIAS4', 'PPM1E']",follicular lymphoma,myeloid cell,PSMB5,"Among the candidate genes EN1, PSMB5, SHH, PIAS4, and PPM1E, which one exhibits the highest level of myeloid cell-specific expression and shows the greatest potential as a therapeutic target for follicular lymphoma?","Among the candidate genes EN1, PSMB5, SHH, PIAS4, and PPM1E, which one exhibits the highest level of myeloid cell-specific expression and shows the greatest potential as a therapeutic target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which myeloid cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific candidate genes. Compute the average embedding of this candidate set and then calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HILPDA', 'ITGA7', 'NDUFB7', 'COL9A2', 'MLX']",follicular lymphoma,myeloid cell,NDUFB7,"Among HILPDA, ITGA7, NDUFB7, COL9A2, and MLX, which gene exhibits the highest specificity in myeloid cells for use as a therapeutic target in follicular lymphoma?","Among HILPDA, ITGA7, NDUFB7, COL9A2, and MLX, which gene exhibits the highest specificity in myeloid cells for use as a therapeutic target in follicular lymphoma? Retrieve the cell-type–specific embeddings from PINNACLE for verified therapeutic targets of follicular lymphoma. Identify the overlap between these targets and the myeloid cell–activated genes catalogued in PINNACLE, and compute the average embedding for this intersecting set. Next, calculate the cosine similarity between this average embedding and the embedding of each target gene. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABR', 'GRXCR1', 'SSBP3', 'TLR1', 'PIK3R5']",follicular lymphoma,myeloid cell,PIK3R5,"Among the genes ABR, GRXCR1, SSBP3, TLR1, and PIK3R5, which exhibits the highest myeloid cell specificity for targeting follicular lymphoma?","Among the genes ABR, GRXCR1, SSBP3, TLR1, and PIK3R5, which exhibits the highest myeloid cell specificity for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, identify which myeloid cell-activated genes in PINNACLE overlap with these therapeutic targets to define a set of follicular lymphoma cell-type–specific targets. Compute the average embedding for this overlapping set, and then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale regarding its biological relevance."
"['MCRIP2', 'GGT6', 'NDUFA9', 'C14orf180', 'HAPLN1']",follicular lymphoma,myeloid cell,NDUFA9,"Which of the following genes—MCRIP2, GGT6, NDUFA9, C14orf180, or HAPLN1—exhibits the highest specificity for myeloid cells in the context of targeting follicular lymphoma?","Which of the following genes—MCRIP2, GGT6, NDUFA9, C14orf180, or HAPLN1—exhibits the highest specificity for myeloid cells in the context of targeting follicular lymphoma? Identify the known therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the myeloid cell-activated genes in the dataset. For the overlapping genes, compute an average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-DRB5', 'CAMK2A', 'CCL23', 'DMTN', 'RAB26']",follicular lymphoma,myeloid cell,HLA-DRB5,"Among HLA-DRB5, CAMK2A, CCL23, DMTN, and RAB26, which gene exhibits the most specific expression in myeloid cells and represents the best candidate for targeting follicular lymphoma?","Among HLA-DRB5, CAMK2A, CCL23, DMTN, and RAB26, which gene exhibits the most specific expression in myeloid cells and represents the best candidate for targeting follicular lymphoma? Identify confirmed therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, from the set of myeloid cell-activated genes in PINNACLE, determine which genes overlap with these targets to define the cell-type-specific targets for follicular lymphoma. Compute the average embedding for this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target gene. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based explanation for its biological relevance."
"['ZNF277', 'PIK3CD', 'RABEPK', 'ZBTB24', 'SLC34A3']",follicular lymphoma,myeloid cell,PIK3CD,"Among the genes ZNF277, PIK3CD, RABEPK, ZBTB24, and SLC34A3, which one displays the highest level of myeloid cell-specific expression relevant to follicular lymphoma targeting?","Among the genes ZNF277, PIK3CD, RABEPK, ZBTB24, and SLC34A3, which one displays the highest level of myeloid cell-specific expression relevant to follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in myeloid cells, and compute the average embedding of the overlapping set as a reference. Then, calculate the cosine similarity between this reference embedding and each target's embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['EPHA3', 'IGHM', 'ASS1', 'ZNF217', 'POLD4']",follicular lymphoma,myeloid cell,POLD4,"Among EPHA3, IGHM, ASS1, ZNF217, and POLD4, which gene exhibits the highest specificity in myeloid cells for potential targeted intervention in follicular lymphoma?","Among EPHA3, IGHM, ASS1, ZNF217, and POLD4, which gene exhibits the highest specificity in myeloid cells for potential targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the myeloid cell-activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. Finally, if one gene shows a noticeably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NMBR', 'WNK1', 'TMEM54', 'NDUFAF4', 'IL17RB']",follicular lymphoma,myeloid cell,NDUFAF4,"Which gene among NMBR, WNK1, TMEM54, NDUFAF4, and IL17RB exhibits the highest cell-type specificity in myeloid cells, making it the optimal candidate for targeted therapy in follicular lymphoma?","Which gene among NMBR, WNK1, TMEM54, NDUFAF4, and IL17RB exhibits the highest cell-type specificity in myeloid cells, making it the optimal candidate for targeted therapy in follicular lymphoma? For follicular lymphoma, compile a list of verified therapeutic targets and obtain their cell-type specific embeddings from PINNACLE. Identify the subset of these targets that overlaps with PINNACLE’s myeloid cell-activated genes to define the cell-type specific targets for the disease. Next, compute the average embedding for this overlapping set, then determine the cosine similarity between the reference vector and each individual target’s embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['ZNF329', 'RUVBL2', 'MT-ND5', 'NOL7', 'CXorf66']",follicular lymphoma,myeloid cell,MT-ND5,"Among the genes ZNF329, RUVBL2, MT-ND5, NOL7, and CXorf66, which one exhibits the highest specificity for myeloid cells, making it the most promising candidate for targeted intervention in follicular lymphoma?","Among the genes ZNF329, RUVBL2, MT-ND5, NOL7, and CXorf66, which one exhibits the highest specificity for myeloid cells, making it the most promising candidate for targeted intervention in follicular lymphoma? Using PINNACLE, extract the cell-type–specific embeddings for validated therapeutic targets of follicular lymphoma. Next, identify which of these targets overlap with the myeloid cell–activated genes in PINNACLE. Calculate the average embedding of the overlapping genes and determine the cosine similarity between this average and each individual target embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PKN1', 'MIDEAS', 'RPL18A', 'TUBB4B', 'PROSER2']",follicular lymphoma,myeloid cell,TUBB4B,"Among the genes PKN1, MIDEAS, RPL18A, TUBB4B, and PROSER2, which one exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma?","Among the genes PKN1, MIDEAS, RPL18A, TUBB4B, and PROSER2, which one exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma? Identify experimentally validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embedding data from PINNACLE. Next, determine which myeloid cell-activated genes in PINNACLE overlap with these targets to define a set of candidate genes. Compute the average embedding vector for this candidate set and calculate the cosine similarity between this reference vector and the individual gene embeddings. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PGM3', 'ICOS', 'NPM1', 'MT-ND4L', 'TBX20']",follicular lymphoma,myeloid cell,MT-ND4L,"Among the genes PGM3, ICOS, NPM1, MT-ND4L, and TBX20, which is most specifically expressed in myeloid cells, making it the optimal candidate for targeting follicular lymphoma?","Among the genes PGM3, ICOS, NPM1, MT-ND4L, and TBX20, which is most specifically expressed in myeloid cells, making it the optimal candidate for targeting follicular lymphoma? Identify confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Then, from the myeloid cell-activated genes available in PINNACLE, determine which ones overlap with these targets to form a set of cell-type–specific targets for the disease. Compute the average embedding of this set and calculate the cosine similarity between this average and each individual gene embedding. If one gene shows significantly higher similarity than the others, nominate it as the prime candidate, providing a concise, evidence-based rationale for its biological relevance."
"['KRT1', 'NDUFB5', 'CNIH3', 'NDRG2', 'CNNM4']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB5,"Which gene—KRT1, NDUFB5, CNIH3, NDRG2, or CNNM4—exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeted follicular lymphoma therapy?","Which gene—KRT1, NDUFB5, CNIH3, NDRG2, or CNNM4—exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which plasmacytoid dendritic cell–activated genes in PINNACLE overlap with these follicular lymphoma targets, forming a set of cell-type specific targets. Calculate the average embedding for this set and then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NFE2', 'NBPF3', 'HDAC9', 'DSTN', 'SCAMP1']",follicular lymphoma,plasmacytoid dendritic cell,HDAC9,"Among the genes NFE2, NBPF3, HDAC9, DSTN, and SCAMP1, which exhibits the highest specificity in plasmacytoid dendritic cells, making it the single best candidate for targeted therapy in follicular lymphoma?","Among the genes NFE2, NBPF3, HDAC9, DSTN, and SCAMP1, which exhibits the highest specificity in plasmacytoid dendritic cells, making it the single best candidate for targeted therapy in follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the plasmacytoid dendritic cell–activated genes in PINNACLE. For the overlapping gene set, compute the average embedding as a reference, then calculate the cosine similarity between this reference and each individual target embedding. Finally, if one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in follicular lymphoma."
"['NDUFS3', 'FGF17', 'ATF5', 'CACNA1A', 'CRAT']",follicular lymphoma,plasmacytoid dendritic cell,NDUFS3,"Which gene among NDUFS3, FGF17, ATF5, CACNA1A, and CRAT demonstrates the highest specificity for plasmacytoid dendritic cells in the context of targeted follicular lymphoma therapy?","Which gene among NDUFS3, FGF17, ATF5, CACNA1A, and CRAT demonstrates the highest specificity for plasmacytoid dendritic cells in the context of targeted follicular lymphoma therapy? Which verified therapeutic targets for follicular lymphoma have cell-type–specific embeddings in PINNACLE? Retrieve these embeddings and identify which targets overlap with genes activated in plasmacytoid dendritic cells. Using this overlapping set as the cell-type–specific targets for follicular lymphoma, compute their average embedding to serve as a reference, then determine the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MSH5', 'VSIR', 'RAP1B', 'GTF2H4', 'NDUFS5']",follicular lymphoma,plasmacytoid dendritic cell,NDUFS5,"Which gene among MSH5, VSIR, RAP1B, GTF2H4, and NDUFS5 exhibits the highest cell-type-specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among MSH5, VSIR, RAP1B, GTF2H4, and NDUFS5 exhibits the highest cell-type-specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Identify which of these targets overlap with genes activated in plasmacytoid dendritic cells, defining a set of cell-type–specific targets. Calculate the average embedding for this set and then compute the cosine similarity between this average and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SAT1', 'POLD2', 'MED12', 'DAZAP1', 'MYOM1']",follicular lymphoma,plasmacytoid dendritic cell,POLD2,"Among the genes SAT1, POLD2, MED12, DAZAP1, and MYOM1, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeted intervention in follicular lymphoma?","Among the genes SAT1, POLD2, MED12, DAZAP1, and MYOM1, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeted intervention in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which plasmacytoid dendritic cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set and calculate the cosine similarity between the average and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CD38', 'FAM98A', 'COX6A1', 'PPP1R3F', 'PRR5L']",follicular lymphoma,plasmacytoid dendritic cell,CD38,"Among the genes CD38, FAM98A, COX6A1, PPP1R3F, and PRR5L, which one exhibits the highest specificity for plasmacytoid dendritic cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among the genes CD38, FAM98A, COX6A1, PPP1R3F, and PRR5L, which one exhibits the highest specificity for plasmacytoid dendritic cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify verified therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and plasmacytoid dendritic cell–activated genes in PINNACLE. Compute the average embedding of the overlapping gene set and evaluate the cosine similarity between this reference and each individual target embedding. If a single gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological significance."
"['DDB1', 'CCDC70', 'MFAP3', 'RAB3A', 'C5orf24']",follicular lymphoma,plasmacytoid dendritic cell,DDB1,"Which gene among DDB1, CCDC70, MFAP3, RAB3A, and C5orf24 exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among DDB1, CCDC70, MFAP3, RAB3A, and C5orf24 exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Which verified therapeutic targets for follicular lymphoma can be extracted from PINNACLE along with their cell-type–specific embeddings? Using the list of plasmacytoid dendritic cell-activated genes in PINNACLE, identify the overlapping genes with these lymphoma targets. Next, compute the average embedding for this overlapping set and calculate the cosine similarity between the reference embedding and each individual gene's embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ATM', 'STIP1', 'CDH17', 'SHISA6', 'LYN']",follicular lymphoma,plasmacytoid dendritic cell,LYN,"Which gene among ATM, STIP1, CDH17, SHISA6, and LYN exhibits the highest cell-type specificity in plasmacytoid dendritic cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among ATM, STIP1, CDH17, SHISA6, and LYN exhibits the highest cell-type specificity in plasmacytoid dendritic cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the plasmacytoid dendritic cell–activated genes in PINNACLE to compile a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity of each individual target to this reference. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SYT13', 'NDUFB11', 'MALT1', 'POLR3K', 'UBE3D']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB11,"Among the genes SYT13, NDUFB11, MALT1, POLR3K, and UBE3D, which one exhibits the greatest specificity of expression in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma?","Among the genes SYT13, NDUFB11, MALT1, POLR3K, and UBE3D, which one exhibits the greatest specificity of expression in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, compare these targets with the plasmacytoid dendritic cell-activated genes in PINNACLE to identify the overlapping set, which represents cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference, and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DNMT1', 'TMPRSS3', 'ALDH4A1', 'FIG4', 'HLA-DQA1']",follicular lymphoma,plasmacytoid dendritic cell,DNMT1,"Which gene among DNMT1, TMPRSS3, ALDH4A1, FIG4, and HLA-DQA1 demonstrates the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among DNMT1, TMPRSS3, ALDH4A1, FIG4, and HLA-DQA1 demonstrates the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, identify the overlapping genes between these targets and the plasmacytoid dendritic cell–activated genes in PINNACLE to establish a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set and calculate the cosine similarity between the reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['KLHDC10', 'NDUFC1', 'DCK', 'PES1', 'LOXL2']",follicular lymphoma,plasmacytoid dendritic cell,NDUFC1,"Among the genes KLHDC10, NDUFC1, DCK, PES1, and LOXL2, which one exhibits the most specific expression in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma therapy?","Among the genes KLHDC10, NDUFC1, DCK, PES1, and LOXL2, which one exhibits the most specific expression in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma therapy? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which plasmacytoid dendritic cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set for follicular lymphoma. Compute the average embedding of these overlapping targets and calculate the cosine similarity between this reference embedding and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based justification for its biological relevance."
"['KMT2C', 'KLK1', 'PPP1R1A', 'BABAM2', 'IFNAR1']",follicular lymphoma,plasmacytoid dendritic cell,IFNAR1,"Among the genes KMT2C, KLK1, PPP1R1A, BABAM2, and IFNAR1, which one shows the highest cell-type specificity for plasmacytoid dendritic cells in the context of targeting follicular lymphoma?","Among the genes KMT2C, KLK1, PPP1R1A, BABAM2, and IFNAR1, which one shows the highest cell-type specificity for plasmacytoid dendritic cells in the context of targeting follicular lymphoma? Identify the cell‐type–specific therapeutic targets for follicular lymphoma by retrieving their embeddings from PINNACLE. Next, determine the overlap between these targets and the plasmacytoid dendritic cell–activated genes in PINNACLE. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PSMB5', 'UQCC3', 'PCP2', 'FAM214B', 'DYRK1A']",follicular lymphoma,plasmacytoid dendritic cell,PSMB5,"Which gene among PSMB5, UQCC3, PCP2, FAM214B, and DYRK1A exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among PSMB5, UQCC3, PCP2, FAM214B, and DYRK1A exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell–activated genes in PINNACLE. Using this overlapping set as the cell-type–specific targets for follicular lymphoma, calculate their average embedding and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['NUP160', 'NDUFAF3', 'NAT8L', 'SRP14', 'SFTPC']",follicular lymphoma,plasmacytoid dendritic cell,NDUFAF3,"Among the genes NUP160, NDUFAF3, NAT8L, SRP14, and SFTPC, which exhibits the highest specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes NUP160, NDUFAF3, NAT8L, SRP14, and SFTPC, which exhibits the highest specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell-activated genes in PINNACLE. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target gene. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MAGEA2B', 'SH3RF3', 'CASZ1', 'NDUFB3', 'RARS2']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB3,"Among the genes MAGEA2B, SH3RF3, CASZ1, NDUFB3, and RARS2, which one displays the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes MAGEA2B, SH3RF3, CASZ1, NDUFB3, and RARS2, which one displays the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Retrieve the validated therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings from PINNACLE. Identify which of these targets overlap with the plasmacytoid dendritic cell–activated genes in PINNACLE to define a set of cell-type–specific targets for follicular lymphoma. Next, compute the average embedding of this overlapping set and calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFNAR2', 'ZNF480', 'AQP9', 'DEGS1', 'TOP3B']",follicular lymphoma,plasmacytoid dendritic cell,IFNAR2,"Among the genes IFNAR2, ZNF480, AQP9, DEGS1, and TOP3B, which one exhibits the highest cell-type–specific expression in plasmacytoid dendritic cells with potential relevance for targeting follicular lymphoma?","Among the genes IFNAR2, ZNF480, AQP9, DEGS1, and TOP3B, which one exhibits the highest cell-type–specific expression in plasmacytoid dendritic cells with potential relevance for targeting follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with plasmacytoid dendritic cell-activated genes in PINNACLE to obtain a refined set of targets. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['CXCR4', 'ZNF473', 'SLC43A1', 'EMC10', 'RGL4']",follicular lymphoma,plasmacytoid dendritic cell,CXCR4,"Among the genes CXCR4, ZNF473, SLC43A1, EMC10, and RGL4, which one demonstrates the highest expression specificity in plasmacytoid dendritic cells for targeted follicular lymphoma therapy?","Among the genes CXCR4, ZNF473, SLC43A1, EMC10, and RGL4, which one demonstrates the highest expression specificity in plasmacytoid dendritic cells for targeted follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which plasmacytoid dendritic cell-activated genes from PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for these overlapping genes, then compute the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF692', 'NDUFA7', 'HNMT', 'SPRED1', 'WDR75']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA7,"Among the genes ZNF692, NDUFA7, HNMT, SPRED1, and WDR75, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells with potential relevance for follicular lymphoma targeting?","Among the genes ZNF692, NDUFA7, HNMT, SPRED1, and WDR75, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells with potential relevance for follicular lymphoma targeting? Using the validated therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the genes activated in plasmacytoid dendritic cells within PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference point, then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance in the context of follicular lymphoma."
"['NEUROD1', 'DMD', 'SPANXN2', 'TUBB6', 'LACTB2']",follicular lymphoma,plasmacytoid dendritic cell,TUBB6,"Which gene among NEUROD1, DMD, SPANXN2, TUBB6, and LACTB2 exhibits the highest specificity in plasmacytoid dendritic cells for potential targeting in follicular lymphoma?","Which gene among NEUROD1, DMD, SPANXN2, TUBB6, and LACTB2 exhibits the highest specificity in plasmacytoid dendritic cells for potential targeting in follicular lymphoma? Identify the experimentally validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in plasmacytoid dendritic cells according to PINNACLE data. Using this intersecting gene set as the cell-type–specific targets for follicular lymphoma, compute their average embedding to serve as a reference vector. Then, calculate the cosine similarity between this reference vector and the embedding of each target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FOXG1', 'ONECUT2', 'FBXO38', 'SPTY2D1', 'NDUFA6']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA6,"Which gene among FOXG1, ONECUT2, FBXO38, SPTY2D1, and NDUFA6 exhibits the most specific expression in plasmacytoid dendritic cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among FOXG1, ONECUT2, FBXO38, SPTY2D1, and NDUFA6 exhibits the most specific expression in plasmacytoid dendritic cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the plasmacytoid dendritic cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity compared to the others, nominate it as the prime candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IMPDH1', 'POU4F2', 'ZKSCAN1', 'UST', 'UBLCP1']",follicular lymphoma,b cell,IMPDH1,"Among the candidate genes IMPDH1, POU4F2, ZKSCAN1, UST, and UBLCP1, which exhibits the highest specificity in B cells as a potential target for follicular lymphoma therapy?","Among the candidate genes IMPDH1, POU4F2, ZKSCAN1, UST, and UBLCP1, which exhibits the highest specificity in B cells as a potential target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the B cell-activated genes in PINNACLE to define the candidate cell-type–specific targets for follicular lymphoma. Calculate the average embedding vector for these candidates and assess the cosine similarity between this average and each individual embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-backed rationale for its biological relevance."
"['PKD1L3', 'TYK2', 'DCLRE1A', 'CPT1B', 'CRYBB3']",follicular lymphoma,b cell,TYK2,"Among PKD1L3, TYK2, DCLRE1A, CPT1B, and CRYBB3, which gene exhibits the most B cell-specific expression, thereby representing the best candidate for targeting follicular lymphoma?","Among PKD1L3, TYK2, DCLRE1A, CPT1B, and CRYBB3, which gene exhibits the most B cell-specific expression, thereby representing the best candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the B cell-activated genes in PINNACLE, defining a set of cell-type-specific targets. Calculate the average embedding for this set and then compute the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ACSF2', 'NCOR2', 'AKR1A1', 'TBXA2R', 'POLE3']",follicular lymphoma,b cell,POLE3,"Among the candidate genes ACSF2, NCOR2, AKR1A1, TBXA2R, and POLE3, which one exhibits the highest specificity for B cells, indicating its potential as a target in follicular lymphoma?","Among the candidate genes ACSF2, NCOR2, AKR1A1, TBXA2R, and POLE3, which one exhibits the highest specificity for B cells, indicating its potential as a target in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma from PINNACLE and extract their cell-type-specific embeddings. Next, determine which of these targets overlap with the B cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set to create a reference vector, then compute the cosine similarity between the reference vector and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['BCL2A1', 'KCNC2', 'NOMO2', 'MAGEA2', 'TRIM17']",follicular lymphoma,b cell,BCL2A1,"Among the candidate genes (BCL2A1, KCNC2, NOMO2, MAGEA2, and TRIM17), which one shows the highest B cell-specific expression and would be the most suitable target for follicular lymphoma therapy?","Among the candidate genes (BCL2A1, KCNC2, NOMO2, MAGEA2, and TRIM17), which one shows the highest B cell-specific expression and would be the most suitable target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which B cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping gene set and calculate the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SMN1', 'CD19', 'PCOTH', 'DMWD', 'TNK2']",follicular lymphoma,b cell,CD19,"Among SMN1, CD19, PCOTH, DMWD, and TNK2, which gene shows the highest B cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among SMN1, CD19, PCOTH, DMWD, and TNK2, which gene shows the highest B cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma within PINNACLE and extract their corresponding cell-type–specific embeddings. Then, determine which of these targets overlap with the B cell-activated genes in PINNACLE to define a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set as a reference, and compute the cosine similarity between this reference and each individual gene’s embedding. Finally, nominate the gene with a markedly higher cosine similarity as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['MIA', 'PRIM1', 'HAUS5', 'NEK2', 'GAGE10']",follicular lymphoma,b cell,PRIM1,"Among the genes MIA, PRIM1, HAUS5, NEK2, and GAGE10, which one exhibits the highest B-cell-specific expression, indicating its potential as a targeted therapeutic candidate for follicular lymphoma?","Among the genes MIA, PRIM1, HAUS5, NEK2, and GAGE10, which one exhibits the highest B-cell-specific expression, indicating its potential as a targeted therapeutic candidate for follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Identify the overlap between these targets and the B cell-activated genes provided by PINNACLE, designating this overlapping set as the cell-type–specific targets for follicular lymphoma. Next, compute the average embedding for this set and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['CCDC28A-AS1', 'OR51E1', 'ZNF714', 'DHFR', 'PDIA4']",follicular lymphoma,b cell,DHFR,"Among the genes CCDC28A-AS1, OR51E1, ZNF714, DHFR, and PDIA4, which exhibits the highest B cell-specific expression, thereby serving as the most promising candidate for targeted follicular lymphoma intervention?","Among the genes CCDC28A-AS1, OR51E1, ZNF714, DHFR, and PDIA4, which exhibits the highest B cell-specific expression, thereby serving as the most promising candidate for targeted follicular lymphoma intervention? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of B cell-activated genes in PINNACLE to define the follicular lymphoma-specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ERCC5', 'ZNF69', 'MTMR10', 'ADIRF', 'USP6NL']",follicular lymphoma,b cell,USP6NL,"Which gene among ERCC5, ZNF69, MTMR10, ADIRF, and USP6NL exhibits the highest cell-type specificity in B cells for targeting follicular lymphoma?","Which gene among ERCC5, ZNF69, MTMR10, ADIRF, and USP6NL exhibits the highest cell-type specificity in B cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the intersection between these targets and the set of B cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to establish a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDC80', 'STRN3', 'NDUFA5', 'IFNLR1', 'ADAMTS13']",follicular lymphoma,b cell,NDUFA5,"Which gene among NDC80, STRN3, NDUFA5, IFNLR1, and ADAMTS13 exhibits the most specific expression in B cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among NDC80, STRN3, NDUFA5, IFNLR1, and ADAMTS13 exhibits the most specific expression in B cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets are present among the B cell–activated genes in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of these overlapping targets, then compute the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ATP7A', 'EFNA3', 'SCNN1G', 'PPP3CB', 'BTK']",follicular lymphoma,b cell,BTK,"Among ATP7A, EFNA3, SCNN1G, PPP3CB, and BTK, which gene exhibits the highest specificity of expression in B cells, making it the most promising target for follicular lymphoma therapy?","Among ATP7A, EFNA3, SCNN1G, PPP3CB, and BTK, which gene exhibits the highest specificity of expression in B cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which B cell–activated genes in PINNACLE overlap with these targets, defining this overlapping set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CXCR4', 'MAS1', 'ASCC3', 'SPOCK2', 'HSPB6']",follicular lymphoma,b cell,CXCR4,"Which gene among CXCR4, MAS1, ASCC3, SPOCK2, and HSPB6 exhibits the highest B cell‐specific expression relevant for targeting follicular lymphoma?","Which gene among CXCR4, MAS1, ASCC3, SPOCK2, and HSPB6 exhibits the highest B cell‐specific expression relevant for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets intersect with the set of b cell–activated genes in PINNACLE. Calculate an average embedding for the overlapping genes and then compute the cosine similarity between this average and the individual embeddings for each target. If one gene displays substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CIBAR1', 'IL10RB', 'SLC10A4', 'TBC1D25', 'NDUFS5']",follicular lymphoma,b cell,NDUFS5,"Which gene among CIBAR1, IL10RB, SLC10A4, TBC1D25, and NDUFS5 exhibits the highest B cell-specific expression, making it the most promising target for follicular lymphoma treatment?","Which gene among CIBAR1, IL10RB, SLC10A4, TBC1D25, and NDUFS5 exhibits the highest B cell-specific expression, making it the most promising target for follicular lymphoma treatment? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with PINNACLE’s set of B cell–activated genes to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and, for each individual target, compute the cosine similarity to this reference embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TUBB2A', 'PSMD7', 'KATNBL1', 'CDH5', 'CD53']",follicular lymphoma,b cell,TUBB2A,"Among TUBB2A, PSMD7, KATNBL1, CDH5, and CD53, which gene shows the highest B cell-specific expression, thereby representing the most promising target for follicular lymphoma intervention?","Among TUBB2A, PSMD7, KATNBL1, CDH5, and CD53, which gene shows the highest B cell-specific expression, thereby representing the most promising target for follicular lymphoma intervention? Identify the validated therapeutic targets for follicular lymphoma in the PINNACLE database and extract their cell-type–specific embeddings. Next, determine which of the B cell–activated genes in PINNACLE overlap with these targets; this set will represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target’s embedding. If a single gene displays markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RBP3', 'IFNAR2', 'NDFIP2', 'EIF4ENIF1', 'WDR27']",follicular lymphoma,b cell,IFNAR2,"Among RBP3, IFNAR2, NDFIP2, EIF4ENIF1, and WDR27, which gene shows the highest cell-type specificity in B cells relevant to follicular lymphoma targeting?","Among RBP3, IFNAR2, NDFIP2, EIF4ENIF1, and WDR27, which gene shows the highest cell-type specificity in B cells relevant to follicular lymphoma targeting? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Then, determine which of these targets overlap with the set of B cell–activated genes in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OTUB1', 'CCN2', 'EEF1AKNMT', 'C3orf33', 'NDUFA13']",follicular lymphoma,b cell,NDUFA13,"Among the genes OTUB1, CCN2, EEF1AKNMT, C3orf33, and NDUFA13, which one exhibits the highest B cell specificity for targeting follicular lymphoma?","Among the genes OTUB1, CCN2, EEF1AKNMT, C3orf33, and NDUFA13, which one exhibits the highest B cell specificity for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the b cell-activated genes in PINNACLE, as these overlapping genes represent the cell-type-specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['GOLGA8F', 'PLA2G4C', 'NDUFC2', 'GYS2', 'ZNF714']",follicular lymphoma,b cell,NDUFC2,"Which gene among GOLGA8F, PLA2G4C, NDUFC2, GYS2, and ZNF714 demonstrates the highest cell-type specific expression in B cells for use as a targeted approach in follicular lymphoma?","Which gene among GOLGA8F, PLA2G4C, NDUFC2, GYS2, and ZNF714 demonstrates the highest cell-type specific expression in B cells for use as a targeted approach in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the B cell-activated genes profiled in PINNACLE; this intersection constitutes the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to use as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GHDC', 'MYBPC1', 'CDK4', 'GPATCH1', 'FUZ']",follicular lymphoma,b cell,CDK4,"Which gene among GHDC, MYBPC1, CDK4, GPATCH1, and FUZ exhibits the highest B cell specificity, making it the most promising candidate for targeting follicular lymphoma?","Which gene among GHDC, MYBPC1, CDK4, GPATCH1, and FUZ exhibits the highest B cell specificity, making it the most promising candidate for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the b cell-activated genes in PINNACLE, thereby defining the cell-specific targets for this lymphoma subtype. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between the reference embedding and each individual target embedding. Finally, if one gene exhibits a significantly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KCTD3', 'CACHD1', 'PRR3', 'KCNJ18', 'MT-ND4']",follicular lymphoma,b cell,MT-ND4,"Among KCTD3, CACHD1, PRR3, KCNJ18, and MT-ND4, which gene exhibits the highest B-cell specificity for potential targeting in follicular lymphoma?","Among KCTD3, CACHD1, PRR3, KCNJ18, and MT-ND4, which gene exhibits the highest B-cell specificity for potential targeting in follicular lymphoma? Retrieve verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the B cell–activated genes in PINNACLE to define cell-type–specific targets. Compute the average embedding of the overlapping set to serve as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HLA-DRB1', 'PRPF19', 'USP7', 'PDZRN4', 'NCOR2']",follicular lymphoma,b cell,HLA-DRB1,"Among the genes HLA-DRB1, PRPF19, USP7, PDZRN4, and NCOR2, which one exhibits the highest cell-type specificity in B cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among the genes HLA-DRB1, PRPF19, USP7, PDZRN4, and NCOR2, which one exhibits the highest cell-type specificity in B cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, identify the overlap between these targets and the b cell–activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding of this set and determine the cosine similarity between the average embedding and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AVPR1B', 'AGPS', 'SPRED1', 'POLD1', 'CXorf51B']",follicular lymphoma,b cell,POLD1,"Among the genes AVPR1B, AGPS, SPRED1, POLD1, and CXorf51B, which one exhibits the highest B cell specificity for targeting follicular lymphoma?","Among the genes AVPR1B, AGPS, SPRED1, POLD1, and CXorf51B, which one exhibits the highest B cell specificity for targeting follicular lymphoma? Identify all experimentally validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of b cell–activation-associated genes in PINNACLE to define a refined group of cell-type–specific targets. Calculate the average embedding for this overlapping group to serve as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
